MolProbity logo
When finished, you should . Hint: Use File | Save As... to save a copy of this page.

All-Atom
Contacts
Clashscore, all atoms:3.92 97th percentile* (N=819, 1.70Å ± 0.25Å)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers111.29% Goal: <0.3%
Favored rotamers81895.67% Goal: >98%
Ramachandran outliers40.43% Goal: <0.05%
Ramachandran favored90497.31% Goal: >98%
Rama distribution Z-score-0.36 ± 0.25 Goal: abs(Z score) < 2
MolProbity score^1.3995th percentile* (N=9248, 1.70Å ± 0.25Å)
Cβ deviations >0.25Å20.22% Goal: 0
Bad bonds:2 / 79550.03% Goal: 0%
Bad angles:11 / 107390.10% Goal: <0.1%
Peptide Omegas Cis Prolines: 0 / 34 0.00% Expected: ≤1 per chain, or ≤5%
Additional validations Chiral volume outliers0/1159
Waters with clashes13/6302.06%See UnDowser table for details
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.
Key to table colors and cutoffs here:

#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 4 ARG20.38--Favored (36%) ttt-90
chi angles: 199.9,167.9,180.3,266.3
0.01Å---
A 5 ARG35.2-Favored (55.38%)
General / -79.3,-5.8
Favored (61.8%) mtp180
chi angles: 299.5,195.8,65.7,190.4
0.04Å---
A 6 TRP13.77-Favored (54.45%)
General / -75.3,-7.6
Favored (16.9%) p-90
chi angles: 40.2,261.3
0.05Å---
A 7 PHE14.29-Favored (32.96%)
General / -94.3,119.4
Favored (52.5%) t80
chi angles: 190,80.3
0.09Å---
A 8 HIS15.38-Favored (58.06%)
Pre-Pro / -110.6,109.3
Favored (8.4%) m-70
chi angles: 297.9,231.8
0.05Å---
A 9 PRO18.4-Favored (17.77%)
Trans-Pro / -76.1,-16.7
Favored (40%) Cg_endo
chi angles: 23.4,329.5,25.6
0.10Å---
A 10 ASN35.71-Favored (9.81%)
General / -122.0,6.8
Favored (60.2%) m-40
chi angles: 283.7,311.7
0.08Å---
A 11 ILE23.98-Favored (4.7%)
Ile or Val / -99.4,151.8
Favored (40.9%) pt
chi angles: 61.3,168.1
0.08Å---
A 12 THR19.15-Favored (17.4%)
General / -85.1,165.5
Favored (29.3%) p
chi angles: 69.6
0.03Å---
A 13 GLY17.23-Favored (61.74%)
Glycine / -53.0,-43.8
-----
A 14 VAL19.48-Favored (94.81%)
Ile or Val / -65.2,-42.8
Favored (57.9%) t
chi angles: 170.5
0.05Å---
A 15 GLU32.16-Favored (96.91%)
General / -63.4,-40.3
Favored (70.2%) mt-10
chi angles: 284.9,166.5,331.8
0.06Å---
A 16 ALA18.2-Favored (86.83%)
General / -61.5,-47.2
-0.04Å---
A 17 GLU26.34-Favored (79.9%)
General / -59.1,-48.9
Favored (60.3%) mt-10
chi angles: 281.7,175.5,18.8
0.09Å---
A 18 ASN36.48-Favored (86.09%)
General / -65.9,-37.4
Favored (91.5%) m-40
chi angles: 294,340.4
0.07Å---
A 19 LEU28.32-Favored (78.9%)
General / -59.6,-49.1
Favored (2.1%) mt
chi angles: 258.3,184.7
0.03Å---
A 20 LEU15.28-Favored (74.27%)
General / -69.1,-34.0
Favored (70.3%) mt
chi angles: 288.3,166
0.02Å---
A 21 LEU21.78-Favored (44.41%)
General / -78.9,-29.9
Favored (65.3%) mt
chi angles: 288.2,174.5
0.02Å---
A 22 THR20.99-Favored (12.68%)
General / -101.4,-28.3
Favored (39.9%) p
chi angles: 67.8
0.07Å---
A 23 ARG52.47-Favored (7.84%)
General / -124.2,-5.5
Favored (18%) mtp85
chi angles: 308.3,192.6,61.1,60.8
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 24 GLY15.06-Favored (22.04%)
Glycine / -108.2,-177.6
-----
A 25 VAL9.67-Favored (7.86%)
Ile or Val / -136.4,176.5
Favored (25.6%) m
chi angles: 295.6
0.05Å---
A 26 ASP14.82-Favored (34.21%)
General / -57.0,127.9
Favored (91.2%) m-30
chi angles: 293.5,342.7
0.07Å---
A 27 GLY8.36-Favored (63.69%)
Glycine / 97.3,-6.9
-----
A 28 SER100.42Å
HA with A 100 TYR O
Favored (48.55%)
General / -71.9,145.4
Favored (61.2%) m
chi angles: 293.7
0.07Å---
A 29 PHE10.77-Favored (44.26%)
General / -149.9,159.6
Favored (50.1%) p90
chi angles: 69.2,273.8
0.03Å---
A 30 LEU11.140.42Å
C with A 30 LEU HD12
Favored (40.3%)
General / -149.5,162.4
Favored (2.9%) pp
chi angles: 61.1,78.4
0.03Å---
A 31 ALA11.84-Favored (33.08%)
General / -119.4,154.8
-0.04Å---
A 32 ARG16.810.43Å
NH1 with A 724 HOH O
Favored (30.45%)
Pre-Pro / -156.7,160.9
Favored (21.9%) ptt90
chi angles: 60.3,199.2,171.5,73.8
0.10Å---
A 33 PRO17.76-Favored (31.01%)
Trans-Pro / -77.0,151.9
Allowed (1%) Cg_endo
chi angles: 1,13.8,336.4
0.12Å---
A 34 SER28.02-Favored (38.56%)
General / -77.3,137.1
Favored (38.3%) t
chi angles: 177.3
0.05Å---
A 35 LYS41.95-Favored (17.52%)
General / -90.2,-30.6
Favored (17.7%) mmtt
chi angles: 296.1,285,199.4,209
0.03Å---
A 36 SER40.26-Favored (40.75%)
General / -79.7,-28.7
Favored (49.4%) p
chi angles: 74.6
0.06Å---
A 37 ASN43.55-Favored (28.38%)
Pre-Pro / -137.9,81.2
Favored (57.7%) t0
chi angles: 198.7,40.9
0.07Å---
A 38 PRO29.03-Favored (41.97%)
Trans-Pro / -51.6,132.8
Favored (87.9%) Cg_exo
chi angles: 329.4,38.8,328.1
0.04Å---
A 39 GLY27.42-Favored (18.3%)
Glycine / 110.0,-24.6
-----
A 40 ASP29.460.74Å
OD2 with A 55 LYS HE3
Favored (9.38%)
General / -94.6,170.6
Favored (89.6%) m-30
chi angles: 284,347.6
0.10Å---
A 41 PHE21.1-Favored (24.24%)
General / -134.4,165.8
Favored (68.3%) m-80
chi angles: 303.6,88
0.02Å---
A 42 THR15.17-Favored (37.1%)
General / -135.7,132.6
Favored (84.4%) m
chi angles: 301.8
0.02Å---
A 43 LEU20.53-Favored (27.07%)
General / -98.5,114.6
Favored (63.4%) tp
chi angles: 179.3,58.4
0.15Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 44 SER16.46-Favored (49.38%)
General / -104.3,124.5
Favored (31.2%) m
chi angles: 302.8
0.03Å---
A 45 VAL15.58-Favored (57.43%)
Ile or Val / -133.1,135.0
Favored (33.5%) t
chi angles: 185.1
0.03Å---
A 46 ARG16.8-Favored (38.69%)
General / -93.0,130.2
Favored (40.2%) ttt180
chi angles: 177.9,162.4,160.5,171
0.03Å---
A 47 ARG36.3-Favored (21%)
General / -147.9,135.7
Favored (7.2%) ptt180
chi angles: 60.8,156.5,160.3,189
0.04Å---
A 48 ASN28.26-Favored (30.74%)
General / 52.5,41.0
Allowed (1%) m110
chi angles: 269.9,63.2
0.05Å---
A 49 GLY15.68-Favored (67.46%)
Glycine / 69.2,13.6
-----
A 50 ALA15.43-Favored (17.75%)
General / -128.3,166.9
-0.04Å---
A 51 VAL16.89-Favored (57.03%)
Ile or Val / -114.1,134.4
Favored (64.2%) t
chi angles: 171.4
0.04Å---
A 52 THR23.6-Favored (43.9%)
General / -110.4,141.2
Favored (62.5%) m
chi angles: 303.4
0.02Å---
A 53 HIS21.25-Favored (33.94%)
General / -114.9,118.6
Favored (93.7%) m-70
chi angles: 300,279.7
0.09Å---
A 54 ILE21.2-Favored (69.84%)
Ile or Val / -112.6,127.4
Favored (52.9%) mt
chi angles: 307,172.5
0.03Å---
A 55 LYS38.470.74Å
HE3 with A 40 ASP OD2
Favored (36.82%)
General / -80.1,139.7
Favored (34.1%) tttt
chi angles: 183.9,169.4,171.5,204.1
0.03Å---
A 56 ILE13.95-Favored (66.8%)
Ile or Val / -123.0,122.9
Favored (48.6%) mt
chi angles: 303.6,163.2
0.01Å---
A 57 GLN38.61-Favored (30.65%)
General / -106.6,146.5
Favored (26.3%) tt0
chi angles: 191.7,176.6,281.9
0.10Å---
A 58 ASN13.38-Favored (4.65%)
General / -145.6,109.0
Favored (45.8%) t0
chi angles: 193,334.3
0.01Å---
A 59 THR16.17-Favored (56.15%)
General / -93.9,2.4
Favored (68.4%) p
chi angles: 62.7
0.02Å---
A 60 GLY11.17-Favored (4.85%)
Glycine / 133.9,-9.1
-----
A 61 ASP16.27-Favored (9.11%)
General / -109.6,-28.0
Favored (47.3%) m-30
chi angles: 304.9,315.5
0.03Å---
A 62 TYR26.65-Allowed (0.86%)
General / 179.8,161.1
Favored (2.6%) p90
chi angles: 45.7,67.3
0.02Å---
A 63 TYR16.97-Favored (27.37%)
General / -85.8,120.6
Favored (95.3%) m-80
chi angles: 294.7,86.9
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 64 ASP22.94-Favored (13.79%)
General / -111.5,105.3
Favored (66.5%) t0
chi angles: 181.7,355.4
0.09Å---
A 65 LEU18.16-Favored (32.27%)
General / -86.0,124.2
Favored (40.8%) tp
chi angles: 175.4,67.8
0.08Å---
A 66 TYR30.32-Favored (29.61%)
General / -59.9,127.0
Favored (71.6%) t80
chi angles: 169.8,77.8
0.08Å---
A 67 GLY26.13-Favored (83.94%)
Glycine / 75.9,12.4
-----
A 68 GLY24.48-Favored (4.9%)
Glycine / -139.6,-146.5
-----
A 69 GLU52.32-Favored (2.46%)
General / -114.2,-174.3
Allowed (0.4%) mm-30
chi angles: 251.8,308.5,321.5
0.08Å---
A 70 LYS25.7-Favored (51.96%)
General / -108.3,133.8
Favored (47.6%) mttp
chi angles: 291.8,170.6,178.1,65.4
0.04Å---
A 71 PHE16.77-Favored (46.52%)
General / -130.7,155.5
Favored (90.3%) m-80
chi angles: 291.3,275.9
0.04Å---
A 72 ALA12.38-Favored (39.63%)
General / -79.9,-33.7
-0.07Å---
A 73 THR15.59-Favored (43.92%)
General / -143.5,158.1
Favored (13.7%) p
chi angles: 75.5
0.05Å---
A 74 LEU15.7-Favored (74.78%)
General / -64.7,-32.9
Favored (18.9%) mt
chi angles: 288.1,184.7
0.03Å---
A 75 ALA13.36-Favored (99.89%)
General / -63.0,-42.9
-0.05Å---
A 76 GLU16.59-Favored (84.33%)
General / -65.9,-36.8
Favored (80%) mt-10
chi angles: 285.9,185.1,4.3
0.09Å---
A 77 LEU18-Favored (51.57%)
General / -59.9,-54.0
Favored (7%) tt
chi angles: 183,154.2
0.08Å---
A 78 VAL17.34-Favored (88.98%)
Ile or Val / -65.3,-40.6
Favored (34.2%) t
chi angles: 165.9
0.10Å---
A 79 GLN29.51-Favored (95.04%)
General / -62.2,-40.1
Favored (58.7%) tt0
chi angles: 181.6,184.7,48.1
0.02Å---
A 80 TYR32.33-Favored (78.39%)
General / -61.5,-49.0
Favored (79.9%) t80
chi angles: 175.4,84.1
0.04Å---
A 81 TYR22.13-Favored (59.58%)
General / -75.4,-29.1
Favored (53.4%) m-80
chi angles: 291.1,295.4
0.08Å---
A 82 MET23.76-Favored (66.31%)
General / -71.6,-30.9
Favored (60.8%) mtp
chi angles: 285.4,190.2,70.9
0.02Å---
A 83 GLU55.22-Favored (53.98%)
General / -91.7,-5.3
Favored (8.2%) mt-10
chi angles: 294.8,205.7,286.8
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 84 HIS49.74--Favored (33.3%) m90
chi angles: 282.6,65.3
0.09Å---
A 96 ILE38.68--Favored (5.2%) mt
chi angles: 308.8,151.6
0.01Å---
A 97 GLU36.43-Favored (52.32%)
General / -104.4,129.9
Favored (46.7%) mt-10
chi angles: 283.6,178.9,308.8
0.07Å---
A 98 LEU20.68-Favored (7.68%)
General / -99.5,96.5
Favored (5.6%) mt
chi angles: 298.1,200.3
0.06Å---
A 99 LYS22.81-Favored (4.06%)
General / -106.9,-45.9
Favored (25%) mtpt
chi angles: 300.2,176.9,79.3,158.7
0.03Å---
A 100 TYR11.930.42Å
O with A 28 SER HA
Favored (18.86%)
Pre-Pro / -128.6,106.4
Favored (62.5%) m-80
chi angles: 304.1,289.7
0.07Å---
A 101 PRO12.86-Favored (74.95%)
Trans-Pro / -58.6,136.6
Favored (6.4%) Cg_endo
chi angles: 12.1,342.4,16.4
0.13Å---
A 102 LEU19.97-Favored (25.22%)
General / -102.3,112.5
Favored (5.5%) tt
chi angles: 191.7,150.8
0.04Å---
A 103 ASN17.33-Favored (35.56%)
General / -81.5,138.1
Favored (96.7%) m-40
chi angles: 292.3,333.6
0.06Å---
A 104 CYS17.31-Favored (31.43%)
General / -88.2,138.4
Favored (53.7%) t
chi angles: 181.1
0.11Å---
A 105 ALA20.29-Favored (29.08%)
General / -103.4,-1.1
-0.06Å---
A 106 ASP31.250.54Å
OD1 with A 108 THR HG23
Favored (87.78%)
Pre-Pro / -74.2,127.5
Favored (44.9%) t0
chi angles: 176.7,348.7
0.10Å- OUTLIER(S)
worst is CA-CB-CG: 5.7 σ
-
A 107 PRO16.65-Favored (4.63%)
Trans-Pro / -88.5,6.8
Favored (26.4%) Cg_endo
chi angles: 35.8,319.3,29.9
0.09Å---
A 108 THR34.280.54Å
HG23 with A 106 ASP OD1
Favored (69%)
General / -65.2,-27.9
Favored (5.7%) p
chi angles: 45
0.04Å---
A 109 SER17.78-Favored (30.67%)
General / -103.2,14.9
Favored (54.4%) m
chi angles: 292.4
0.02Å---
A 110 GLU21.78-Favored (32.98%)
General / -80.7,143.6
Favored (32.9%) mm-30
chi angles: 295.7,280.4,13.1
0.04Å---
A 111 AARG22.420.43Å
HB3 with A 111 AARG HH11
Favored (70.73%)
General / -59.6,-32.8
OUTLIER (0.1%)
chi angles: 284.2,181.3,110.7,290.4
0.11Å---
A 111 BARG15.6-Favored (70.82%)
General / -62.2,-30.0
Favored (27.9%) mtm180
chi angles: 297.8,190.3,286.2,138.3
0.01Å---
A 112 TRP10.98-Favored (45.23%)
General / -96.9,-1.8
Favored (12.5%) p-90
chi angles: 40.5,255.7
0.02Å---
A 113 PHE13.32-Favored (41.47%)
General / -97.3,124.5
Favored (59%) t80
chi angles: 185.1,67.9
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 114 HIS29.570.42Å
O with A 115 GLY C
Allowed (1.35%)
General / -127.6,64.6
Favored (79.6%) m-70
chi angles: 293.2,267.2
0.06Å---
A 115 GLY33.950.42Å
C with A 114 HIS O
OUTLIER (0.01)%)
Glycine / -19.2,-96.9
-----
A 116 HIS56.16-Favored (17.82%)
General / -88.7,105.6
Favored (19.4%) t70
chi angles: 199.5,77.8
0.08Å---
A 117 LEU36.25-Favored (5.86%)
General / -157.2,126.2
Favored (17%) tp
chi angles: 169.7,71.2
0.09Å---
A 118 SER29.86-Favored (31.67%)
General / -72.3,160.9
Favored (2.1%) p
chi angles: 42.5
0.01Å---
A 119 GLY27.06-Favored (79.16%)
Glycine / -64.4,-30.9
-----
A 120 LYS49.25-Favored (32.02%)
General / -70.0,-51.5
Allowed (1.2%) ttpp
chi angles: 191.9,222.8,64.6,62.6
0.05Å---
A 121 GLU43.29-Favored (98.6%)
General / -61.4,-42.4
Favored (70.2%) mt-10
chi angles: 296.4,180.5,316.9
0.07Å---
A 122 ALA25.4-Favored (86.9%)
General / -58.7,-41.7
-0.04Å---
A 123 GLU28.79-Favored (86.01%)
General / -66.1,-37.6
Allowed (0.5%) mt-10
chi angles: 250.1,193.4,45.4
0.06Å---
A 124 LYS35.44-Favored (73.83%)
General / -62.1,-50.0
Favored (24.3%) tttm
chi angles: 183.4,154.9,185.1,301.2
0.03Å---
A 125 LEU27.330.47Å
HB3 with A 216 LEU HD21
Favored (89.06%)
General / -66.5,-41.2
Favored (82.9%) mt
chi angles: 293.1,167.3
0.05Å---
A 126 LEU16.59-Favored (71.58%)
General / -70.2,-33.4
Favored (35.7%) mt
chi angles: 282.8,166.8
0.05Å---
A 127 THR26.08-Favored (69.68%)
General / -70.9,-42.6
Favored (34.9%) m
chi angles: 293.2
0.05Å---
A 128 GLU36.79-Favored (19.05%)
General / -86.7,-36.0
Favored (95.2%) mt-10
chi angles: 294.5,176.6,341.6
0.06Å---
A 129 LYS35.2-Favored (11.66%)
General / -115.7,-11.4
Favored (14.1%) mtmt
chi angles: 300.9,207.3,272.6,194.9
0.06Å---
A 130 GLY22.43-Favored (39.44%)
Glycine / -87.3,169.3
-----
A 131 LYS30.34-Favored (3.75%)
General / -140.1,-173.8
Favored (4.3%) pttt
chi angles: 51.4,180.9,194,214.6
0.03Å---
A 132 HIS18.92-Favored (28.15%)
General / -55.3,127.2
Favored (86.4%) t70
chi angles: 174.3,75.5
0.04Å---
A 133 GLY14.18-Favored (87.69%)
Glycine / 84.3,4.9
-----
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 134 SER14.33-Favored (44.5%)
General / -72.8,133.3
Favored (31.5%) m
chi angles: 288.9
0.03Å---
A 135 PHE10.38-Favored (34.58%)
General / -143.9,163.0
Favored (31.1%) p90
chi angles: 71.1,281
0.03Å---
A 136 LEU12.78-Favored (43.99%)
General / -150.4,160.1
Favored (3.7%) pp
chi angles: 59.6,82.3
0.03Å---
A 137 VAL10.56-Favored (59.72%)
Ile or Val / -123.0,136.5
Favored (60.3%) t
chi angles: 179.9
0.03Å---
A 138 ARG21.36-Favored (43.22%)
General / -138.2,159.0
Favored (25.3%) ptt90
chi angles: 57,183.9,193.9,75.2
0.05Å---
A 139 GLU39.84-Favored (45.65%)
General / -73.6,145.0
Favored (43.5%) mt-10
chi angles: 295.6,163.9,28.9
0.04Å---
A 140 SER23.05--Favored (40.3%) t
chi angles: 176.7
0.03Å---
A 145 GLY22.28-------
A 146 ASP19.52-Favored (6.74%)
General / -88.3,177.9
Favored (42%) m-30
chi angles: 289.8,5.1
0.03Å---
A 147 PHE12.14-Favored (24%)
General / -140.0,166.7
Favored (86.8%) m-80
chi angles: 294.7,83.5
0.04Å---
A 148 VAL12.1-Favored (61.96%)
Ile or Val / -131.0,128.1
Favored (50%) t
chi angles: 181.4
0.04Å---
A 149 LEU15.63-Favored (37.27%)
General / -95.9,121.1
Favored (14.6%) tp
chi angles: 166.5,69.4
0.08Å---
A 150 SER10.22-Favored (53.57%)
General / -118.8,127.5
Favored (72.2%) m
chi angles: 295.9
0.01Å---
A 151 VAL16.34-Favored (57.09%)
Ile or Val / -131.6,136.5
Favored (3.1%) t
chi angles: 192.5
0.04Å---
A 152 ARG24.37-Favored (40.51%)
General / -95.2,132.1
Favored (24.2%) ttt180
chi angles: 175.8,170.7,169.5,146.1
0.05Å---
A 153 THR18.33-Favored (43.94%)
General / -124.7,152.3
Favored (10%) p
chi angles: 46.6
0.03Å---
A 154 GLY29.61-Favored (11.95%)
Glycine / 147.8,-144.1
-----
A 155 ASP54.73--Favored (6.7%) m-30
chi angles: 292.5,15.9
0.06Å---
A 165 SER10.13--Favored (48%) m
chi angles: 291
0.05Å---
A 166 LYS11.69-Favored (32.45%)
General / -160.7,163.5
Allowed (1.6%) pttt
chi angles: 50.7,173.9,225,173.1
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 167 VAL9.48-Favored (47.04%)
Ile or Val / -112.2,136.9
Favored (67.7%) t
chi angles: 171.8
0.07Å---
A 168 THR12.6-Favored (53.16%)
General / -117.5,136.6
Favored (93%) m
chi angles: 301
0.03Å---
A 169 HIS18.9-Favored (56.12%)
General / -111.8,128.5
Favored (94%) m-70
chi angles: 304.4,286.2
0.06Å---
A 170 VAL14.74-Favored (69.86%)
Ile or Val / -116.1,122.5
Favored (99%) t
chi angles: 175.6
0.05Å---
A 171 MET30.62-Favored (39.62%)
General / -76.0,131.5
Favored (16.7%) mmt
chi angles: 294.8,290.7,153.5
0.03Å---
A 172 ILE10.36-Favored (37.47%)
Ile or Val / -111.4,111.7
Favored (89%) mt
chi angles: 293.8,165.2
0.01Å---
A 173 ARG28.49-Favored (27.69%)
General / -84.6,146.2
Favored (51.2%) mtp180
chi angles: 293.1,198.2,68.5,179.4
0.02Å---
A 174 CYS28.07-Favored (14.85%)
General / -112.5,106.4
Favored (53.3%) t
chi angles: 184
0.01Å---
A 175 GLN22.46-Favored (27.38%)
General / -123.9,118.6
Favored (36.5%) mt0
chi angles: 308,192.6,63.7
0.07Å---
A 176 GLU41.510.42Å
O with A 177 LEU HB2
Favored (8.13%)
General / 44.4,47.9
Favored (6.9%) mm-30
chi angles: 270.4,288.4,353.4
0.06Å---
A 177 LEU38.120.42Å
HB2 with A 176 GLU O
Allowed (0.77%)
General / 84.2,3.8
Favored (14.9%) mt
chi angles: 293.5,156.9
0.05Å---
A 178 LYS38.110.48Å
NZ with A 188 ASP OD1
Favored (18.68%)
General / -122.2,163.9
Favored (46.6%) mttm
chi angles: 294.1,184.9,182.6,311.4
0.07Å---
A 179 TYR33.57-Favored (46.36%)
General / -117.1,142.9
Favored (45.7%) m-80
chi angles: 306.8,88.4
0.03Å---
A 180 ASP13.48-Favored (37.07%)
General / -153.1,165.0
Favored (4.3%) p0
chi angles: 66.4,87.3
0.06Å---
A 181 VAL15.7-Favored (2%)
Ile or Val / -103.5,23.4
Favored (25.7%) m
chi angles: 299.5
0.10Å---
A 182 GLY14.27-Favored (33.4%)
Glycine / 108.5,-5.9
-----
A 183 GLY11.98-Favored (40.82%)
Glycine / -172.8,167.9
-----
A 184 GLY10.77-Favored (15.42%)
Glycine / 88.4,-139.2
-----
A 185 GLU23.19-Favored (28.21%)
General / -79.9,154.7
Favored (75%) mm-30
chi angles: 300.1,304.3,311
0.04Å---
A 186 ARG14.7-Favored (55.03%)
General / -117.6,128.5
Favored (39.9%) mtp180
chi angles: 298.3,175.6,56.2,221.7
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 187 PHE15.82-Favored (22.85%)
General / -107.8,153.5
Favored (90.4%) m-80
chi angles: 300.7,272.6
0.04Å---
A 188 ASP32.970.48Å
OD1 with A 178 LYS NZ
Favored (57.72%)
General / -82.5,-12.5
Favored (73.1%) m-30
chi angles: 291.5,323.1
0.07Å---
A 189 SER14.21-Favored (36.76%)
General / -159.0,162.6
Favored (78.6%) p
chi angles: 70.4
0.04Å---
A 190 LEU13.53-Favored (81.98%)
General / -65.6,-35.8
Favored (78.5%) mt
chi angles: 289.2,173.1
0.02Å---
A 191 THR17.86-Favored (93.59%)
General / -59.7,-44.7
Favored (15.4%) m
chi angles: 289.5
0.04Å---
A 192 ASP28.41-Favored (87.89%)
General / -66.3,-38.5
Favored (84%) m-30
chi angles: 287,355.9
0.04Å- OUTLIER(S)
worst is CA-CB-CG: 4.5 σ
-
A 193 LEU11.42-Favored (74%)
General / -64.7,-48.7
Favored (7.6%) tt
chi angles: 181.5,151.3
0.06Å---
A 194 VAL13.17-Favored (96.53%)
Ile or Val / -61.6,-43.2
Favored (48.3%) t
chi angles: 169.2
0.05Å---
A 195 GLU35.69-Favored (95.52%)
General / -63.4,-39.8
Favored (77.1%) mm-30
chi angles: 287.4,301,313.1
0.10Å---
A 196 HIS18.94-Favored (85%)
General / -60.4,-47.7
Favored (54.4%) t70
chi angles: 177.2,89.3
0.04Å---
A 197 TYR18.34-Favored (59.29%)
General / -84.7,-7.3
Favored (62.9%) m-80
chi angles: 290.8,291.6
0.14Å---
A 198 LYS26.8-Favored (68.44%)
General / -71.6,-41.9
Favored (28.6%) mtpt
chi angles: 279.3,162.9,81,178.1
0.02Å---
A 199 LYS41.3-Favored (29.45%)
General / -82.4,-31.6
Favored (22.6%) mttt
chi angles: 287.1,157.2,186.3,153.3
0.01Å---
A 200 ASN37.15-Favored (77.25%)
Pre-Pro / -127.2,74.8
Favored (5.7%) m-40
chi angles: 309.9,266.8
0.03Å---
A 201 PRO22.59-Favored (67.87%)
Trans-Pro / -56.0,135.1
Favored (54.4%) Cg_exo
chi angles: 337.3,28.4,336.1
0.10Å---
A 202 MET24.9-Favored (53.09%)
General / -61.2,144.8
Favored (3.5%) mtm
chi angles: 286.8,161.7,313.6
0.03Å---
A 203 VAL18.56-Favored (69.71%)
Ile or Val / -127.5,128.4
Favored (41.8%) t
chi angles: 183.1
0.04Å---
A 204 GLU25.77-Favored (38.14%)
General / -73.5,156.4
Favored (98.6%) mt-10
chi angles: 292.7,181.2,353.5
0.01Å---
A 205 THR31.5-Favored (66.26%)
General / -66.6,-23.9
Favored (66.9%) p
chi angles: 58.6
0.12Å---
A 206 LEU17.72-Favored (57.15%)
General / -91.8,1.5
Favored (5.7%) mp
chi angles: 277.8,71.3
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 207 GLY14.82-Favored (13.82%)
Glycine / 117.2,-13.7
-----
A 208 THR17.97-Favored (17.6%)
General / -60.0,123.6
Favored (33.6%) m
chi angles: 293
0.04Å---
A 209 VAL16.84-Favored (25.63%)
Ile or Val / -84.0,115.1
Favored (71.1%) t
chi angles: 178.6
0.03Å---
A 210 LEU20.82-Favored (7.92%)
General / -81.0,77.1
Favored (91.6%) mt
chi angles: 299.1,177.7
0.06Å---
A 211 GLN28.13-Favored (27.43%)
General / -74.4,124.9
Favored (40.9%) tt0
chi angles: 183.8,191.9,5
0.02Å---
A 212 LEU19.11-Favored (5.46%)
General / -94.9,89.0
Favored (10.5%) mt
chi angles: 315.8,183
0.06Å---
A 213 LYS45.03-Favored (8.82%)
General / -92.5,-44.1
Favored (6.6%) ttmm
chi angles: 192.7,188,287.4,275
0.01Å---
A 214 GLN23.89-Favored (17.79%)
Pre-Pro / -153.6,146.6
Favored (2.3%) pm20
chi angles: 63.4,277.3,321.9
0.02Å---
A 215 PRO16.43-Favored (92.12%)
Trans-Pro / -57.0,143.4
Favored (99.1%) Cg_exo
chi angles: 332.3,41.9,319.7
0.08Å---
A 216 LEU14.130.47Å
HD21 with A 125 LEU HB3
Favored (54.18%)
General / -57.3,132.8
Favored (58.8%) tp
chi angles: 178.7,64.9
0.07Å---
A 217 ASN20.47-Favored (19.38%)
General / -77.9,117.5
Favored (35.5%) t0
chi angles: 184.8,310.4
0.01Å---
A 218 THR14.72-Favored (10.47%)
General / -119.8,-1.7
Favored (52.1%) p
chi angles: 56.5
0.04Å---
A 219 THR11.87-Favored (16.54%)
General / -96.4,-23.6
Favored (37.6%) p
chi angles: 54.3
0.02Å---
A 220 ARG31.79-Favored (38.55%)
General / -64.0,129.1
Favored (38.3%) ttp-110
chi angles: 177.6,173.1,61.8,246.7
0.04Å---
A 221 ILE24.44-Favored (43.29%)
Ile or Val / -131.0,158.3
Favored (6.1%) pt
chi angles: 56.9,153.6
0.04Å---
A 222 ASN26.320.53Å
O with A 225 GLU HG2
Favored (41.49%)
General / -75.2,133.2
Favored (26.8%) t0
chi angles: 187.6,280.4
0.05Å---
A 223 ALA23.23-Favored (49.94%)
General / -51.8,-36.9
-0.04Å---
A 224 ALA33.66-Favored (66.65%)
General / -65.2,-20.9
-0.05Å---
A 225 GLU33.70.53Å
HG2 with A 222 ASN O
Favored (18.17%)
General / -102.7,20.0
Favored (14%) pt0
chi angles: 67.2,198,358
0.07Å---
A 226 ILE19.18-Favored (50.58%)
Ile or Val / -54.7,-40.2
Favored (3.6%) tp
chi angles: 180,56.5
0.10Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 227 GLU43.02-Favored (79.71%)
General / -64.4,-47.3
Favored (34.6%) tt0
chi angles: 177.3,180.4,299.1
0.09Å---
A 228 SER24.3-Favored (83.57%)
General / -57.6,-42.6
Favored (8.4%) t
chi angles: 165.1
0.05Å---
A 229 ARG19.29-Favored (81.11%)
General / -68.5,-39.7
Favored (15.1%) tpp80
chi angles: 179.9,49.3,53.2,98
0.07Å---
A 230 VAL16.860.73Å
CG1 with A 516 MET HE1
Favored (83.81%)
Ile or Val / -63.2,-39.0
Favored (32.3%) t
chi angles: 165.5
0.10Å---
A 231 ARG41.79-Favored (76.41%)
General / -61.3,-49.6
Favored (27.3%) ttp-110
chi angles: 198.3,169.7,61.7,244.7
0.04Å---
A 232 GLU39.83-Favored (98.82%)
General / -62.6,-41.1
Favored (56.8%) mm-30
chi angles: 286.9,296.1,298.8
0.02Å---
A 233 LEU16.82-Favored (60.57%)
General / -74.8,-17.9
Favored (31%) mt
chi angles: 283.3,173.9
0.03Å---
A 234 SER27.14-Favored (57.02%)
General / -85.7,-9.5
Favored (43.9%) m
chi angles: 290.3
0.02Å---
A 235 LYS48.36-Favored (22.68%)
General / -77.8,166.6
Favored (27.7%) mttt
chi angles: 301.5,195.4,203.1,166.1
0.06Å---
A 236 LEU35.14-Favored (47.72%)
General / -71.7,137.3
Favored (65.2%) mt
chi angles: 294.3,181.2
0.03Å---
A 237 ALA36.9---0.04Å---
A 244 LYS50.210.61Å
HD3 with A 248 TRP CE3
-Allowed (1.8%) ptpt
chi angles: 91.3,173.7,48.7,162.4
0.10Å---
A 245 GLN41.31-Favored (5.08%)
General / -100.3,177.3
Favored (13.7%) mt0
chi angles: 308,175.9,116
0.03Å---
A 246 GLY17.53-Favored (57.74%)
Glycine / -55.0,-34.0
-----
A 247 PHE17.04-Favored (74.31%)
General / -56.2,-40.5
Favored (28.4%) m-80
chi angles: 279.2,291.3
0.10Å---
A 248 TRP31.890.61Å
CE3 with A 244 LYS HD3
Favored (79.83%)
General / -64.6,-47.1
Favored (46.7%) t60
chi angles: 194.8,93.8
0.03Å---
A 249 GLU38.330.41Å
HG2 with A 601 5OD H3
Favored (91.38%)
General / -59.6,-45.6
Favored (7.9%) tt0
chi angles: 180.3,153.7,320.9
0.09Å---
A 250 GLU14.94-Favored (78.63%)
General / -68.6,-42.0
Favored (30.1%) tt0
chi angles: 188.1,177.5,286.6
0.07Å---
A 251 PHE15.51-Favored (92.56%)
General / -64.5,-44.0
Favored (68.1%) t80
chi angles: 179.9,67.3
0.03Å---
A 252 GLU22.25-Favored (65.48%)
General / -68.9,-27.1
Favored (40.4%) mm-30
chi angles: 283.8,304.1,332.3
0.15Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 253 THR13.05-Favored (79.86%)
General / -68.5,-37.3
Favored (98.3%) m
chi angles: 300.6
0.09Å---
A 254 LEU14.29-Favored (89.63%)
General / -64.2,-45.1
Favored (64.3%) tp
chi angles: 175.3,61.4
0.07Å---
A 255 GLN16.25-Favored (74.25%)
General / -62.1,-33.3
Favored (10.8%) mm110
chi angles: 298,298.3,74.7
0.08Å---
A 256 GLN29.74-Favored (67.87%)
General / -62.0,-25.9
Favored (45.8%) tt0
chi angles: 179.2,175.4,299.6
0.06Å---
A 257 GLN19-Favored (53.43%)
General / -87.2,1.3
Favored (97.6%) mm-40
chi angles: 291.9,299.2,303.1
0.04Å---
A 258 GLU18.64-Favored (61.77%)
General / -72.5,-16.5
Favored (9.3%) pt0
chi angles: 81.6,189,2.4
0.07Å---
A 259 ACYS27.84-Favored (56.46%)
General / -73.3,-8.6
OUTLIER (0.2%)
chi angles: 256.2
0.08Å---
A 259 BCYS18.86-Favored (60.43%)
General / -71.3,-10.8
Favored (23%) p
chi angles: 59
0.02Å---
A 260 LYS31.35-Favored (59.59%)
General / -79.6,-9.2
Allowed (1%) mttm
chi angles: 294.6,216.3,187.5,347.3
0.03Å---
A 261 LEU16.29-Favored (11.32%)
General / -113.3,25.4
Favored (69.1%) mt
chi angles: 302,182.7
0.08Å---
A 262 LEU17.38-Favored (8%)
General / -84.8,63.4
Favored (70.2%) mt
chi angles: 295.5,167.3
0.10Å---
A 263 TYR26.74-Favored (25.96%)
General / -80.1,159.9
Favored (42%) m-80
chi angles: 301.5,302.3
0.02Å---
A 264 SER19.63-Favored (54.77%)
General / -64.0,146.1
Favored (95.4%) p
chi angles: 66.1
0.08Å---
A 265 ARG33.94-Favored (2.63%)
General / -136.3,40.8
Allowed (0.6%) mtp-110
chi angles: 297.9,126.9,74.7,234.5
0.05Å---
A 266 LYS39.25-Favored (98.79%)
General / -63.1,-40.9
Favored (10.5%) mttt
chi angles: 294.7,168.4,191,138.8
0.01Å---
A 267 GLU20.09-Favored (93.66%)
General / -60.9,-40.5
Favored (75.8%) mm-30
chi angles: 289.4,295.9,324.8
0.10Å---
A 268 GLY15.36-Favored (69.54%)
Glycine / -67.3,-18.6
-----
A 269 GLN30.38-Favored (41.65%)
General / -91.6,-10.1
Favored (91.6%) mt0
chi angles: 291,166.6,332
0.04Å---
A 270 ARG43.63-Favored (58.5%)
General / -63.8,142.2
Favored (9.6%) mtp85
chi angles: 295.2,172.3,91.9,106.5
0.06Å---
A 271 GLN24.49-Favored (12.75%)
General / -45.2,-48.6
Favored (64.1%) tp40
chi angles: 173.9,59,48.6
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 272 GLU44.480.95Å
CB with A 301 VAL HG11
Favored (64.65%)
General / -67.0,-16.9
Allowed (1.5%) pm20
chi angles: 51.2,246.6,53.5
0.13Å---
A 273 ASN13.37-Favored (16.38%)
General / -107.2,-8.7
Favored (94.5%) m-40
chi angles: 291.6,330.6
0.05Å---
A 274 LYS35.89-Favored (78.76%)
General / -56.0,-46.5
Favored (60%) mttt
chi angles: 285.7,168.1,189.2,162.1
0.04Å---
A 275 ASN34.34-Favored (13.39%)
General / -81.3,6.7
Favored (29.1%) p0
chi angles: 73.5,356.3
0.09Å---
A 276 LYS16.01-Favored (55.71%)
General / -94.4,3.0
Favored (68.9%) mttt
chi angles: 301.6,165.6,190.1,172.9
0.04Å---
A 277 ASN11.39-Favored (54.88%)
General / -107.5,130.2
Favored (79.3%) m-40
chi angles: 301.2,310
0.11Å---
A 278 ARG19.82-Favored (92.91%)
General / -65.3,-42.6
Favored (35.3%) ttm-80
chi angles: 186.9,172.7,272.7,284.5
0.05Å---
A 279 TYR21.67-Favored (33.81%)
General / -118.7,119.2
Favored (65.7%) m-80
chi angles: 305,283.5
0.14Å---
A 280 LYS54.76-Favored (9.06%)
General / -47.2,-36.5
Allowed (1.2%) tttt
chi angles: 160.7,192.4,199.1,232.4
0.06Å---
A 281 ASN31.22-Favored (24.97%)
General / -109.0,6.2
Favored (75.7%) m-40
chi angles: 299.5,302.5
0.06Å---
A 282 ILE14.41-Favored (11.26%)
Ile or Val / -103.7,100.8
Favored (81.9%) mt
chi angles: 297.4,174.6
0.11Å---
A 283 LEU16.27-Favored (69.45%)
Pre-Pro / -127.2,158.4
Favored (70.9%) mt
chi angles: 301,172.5
0.08Å---
A 284 PRO11.15-Favored (9.31%)
Trans-Pro / -82.9,138.7
Favored (76.3%) Cg_endo
chi angles: 28.2,329.6,21.7
0.07Å---
A 285 PHE12.15-Favored (55.06%)
General / -57.8,138.9
Favored (26%) m-80
chi angles: 297.2,315.9
0.09Å---
A 286 ASP17.97-Favored (73.81%)
General / -60.5,-34.2
Favored (76%) m-30
chi angles: 296.7,325.3
0.04Å---
A 287 HIS21.74-Favored (58.85%)
General / -79.4,-14.6
Favored (31.4%) p-80
chi angles: 77.4,286
0.11Å---
A 288 THR13.67-Favored (7.36%)
General / -125.8,5.5
Favored (28%) p
chi angles: 52.6
0.05Å---
A 289 ARG12.38-Favored (45.29%)
General / -65.7,152.0
Favored (23.9%) ptt90
chi angles: 73.1,179.6,185.7,104.7
0.02Å---
A 290 VAL14.3-Favored (19.75%)
Ile or Val / -77.4,115.7
Favored (86.1%) t
chi angles: 177.3
0.06Å---
A 291 VAL12.17-Favored (44.94%)
Ile or Val / -92.3,125.5
Favored (55%) t
chi angles: 180.6
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 292 LEU15.39-Favored (37.3%)
General / -94.1,123.2
Favored (81.6%) mt
chi angles: 299.6,180
0.04Å---
A 293 HIS21.73-Favored (7.68%)
General / -100.1,171.7
Favored (94.7%) m-70
chi angles: 300.3,280.8
0.08Å---
A 294 ASP46.05-Favored (28.07%)
General / 56.7,36.7
Favored (4.6%) t0
chi angles: 210.8,22.5
0.08Å---
A 295 GLY27.06-Favored (54.03%)
Glycine / -73.7,161.4
-----
A 296 ASP33.99-Allowed (1.12%)
Pre-Pro / -40.6,114.7
Favored (63.3%) t0
chi angles: 188.2,346
0.07Å---
A 297 PRO33.63-Favored (22.8%)
Trans-Pro / -51.9,-25.9
Favored (81.8%) Cg_exo
chi angles: 334.6,31.8,333.4
0.12Å---
A 298 ASN45.74-Favored (54.49%)
General / -95.3,1.2
Favored (22.3%) m110
chi angles: 289.3,121.3
0.03Å---
A 299 GLU50.05-Favored (53.33%)
Pre-Pro / -98.0,109.8
Favored (5.2%) mm-30
chi angles: 275.4,298.2,2.3
0.11Å---
A 300 PRO36.14-Favored (59.44%)
Trans-Pro / -51.0,-38.8
Favored (24.3%) Cg_exo
chi angles: 325.9,34.2,338
0.04Å---
A 301 VAL29.030.95Å
HG11 with A 272 GLU CB
Favored (3.6%)
Ile or Val / -131.0,98.5
Allowed (0.6%) p
chi angles: 49.1
0.03Å---
A 302 SER21.86-Favored (11.47%)
General / -120.7,12.6
Favored (35.4%) p
chi angles: 55.4
0.07Å---
A 303 ASP26.37-Favored (38.41%)
General / -103.3,7.4
Favored (9.9%) p0
chi angles: 79.1,350
0.04Å---
A 304 TYR11.57-Favored (51.68%)
General / -113.9,137.4
Favored (82.6%) t80
chi angles: 180.1,84.5
0.07Å---
A 305 ILE12.64-Favored (19.03%)
Ile or Val / -144.9,147.4
Favored (18.1%) tt
chi angles: 184.9,163.6
0.12Å---
A 306 ASN11.64-Favored (6.52%)
General / -82.3,88.3
Favored (45.4%) t0
chi angles: 190.7,320
0.07Å---
A 307 ALA10.96-Favored (12.73%)
General / -161.8,146.2
-0.10Å---
A 308 ASN10.77-Favored (51.82%)
General / -132.1,146.1
Favored (19.1%) m110
chi angles: 297.3,90.2
0.06Å---
A 309 ILE21.380.43Å
HD13 with A 328 ILE HG12
Favored (32.45%)
Ile or Val / -75.2,132.9
Favored (9.6%) mm
chi angles: 298.3,284.2
0.03Å---
A 310 ILE13.09-Favored (47.92%)
Ile or Val / -116.0,115.0
Favored (12.8%) mm
chi angles: 313.7,294.6
0.05Å---
A 311 MET39.96-Favored (20.78%)
Pre-Pro / -107.6,132.7
Favored (62.3%) mtm
chi angles: 301.3,193.1,286.6
0.12Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 312 PRO26.09-Favored (60.27%)
Trans-Pro / -71.6,153.0
Favored (51%) Cg_endo
chi angles: 32.9,317.9,34.9
0.06Å---
A 313 GLU67.68-Allowed (0.59%)
General / 75.7,-56.8
Allowed (1.3%) mt-10
chi angles: 314.1,148.2,284.6
0.10Å---
A 314 PHE50.19--Favored (21.5%) t80
chi angles: 191,56.4
0.04Å---
A 322 LYS40.28--Favored (82.2%) mttt
chi angles: 289.2,182.5,192.5,174.6
0.03Å---
A 323 PRO46.310.42Å
O with A 324 LYS C
Favored (5.5%)
Trans-Pro / -42.0,-50.0
Favored (92%) Cg_exo
chi angles: 333.1,29.1,339.2
0.13Å---
A 324 LYS37.230.42Å
C with A 323 PRO O
Allowed (0.25%)
General / -49.0,-67.6
Allowed (0.7%) mtpt
chi angles: 256.8,200.2,102.1,151
0.08Å---
A 325 LYS48.020.69Å
HD2 with A 912 HOH O
Allowed (0.53%)
General / -81.8,25.8
OUTLIER (0%)
chi angles: 65.1,180.4,35.5,286.4
0.02Å---
A 326 SER19.46-Favored (5.32%)
General / -108.5,175.9
Favored (54%) m
chi angles: 292.3
0.05Å---
A 327 TYR12.4-Favored (34.56%)
General / -134.0,161.5
Favored (6.1%) m-80
chi angles: 313.6,79.4
0.08Å---
A 328 ILE14.990.43Å
HG12 with A 309 ILE HD13
Favored (70.76%)
Ile or Val / -118.9,123.0
Favored (73.5%) mt
chi angles: 293.1,161.3
0.06Å---
A 329 ALA11.74-Favored (45.36%)
General / -102.8,122.9
-0.04Å---
A 330 THR14-Favored (10.95%)
General / -142.4,174.1
Favored (11.8%) t
chi angles: 190.1
0.14Å---
A 331 GLN13.07-Favored (17.36%)
General / -87.3,162.5
Favored (19.7%) pt0
chi angles: 71.9,179.6,13.4
0.02Å---
A 332 GLY14.66-Favored (33.03%)
Glycine / -66.3,132.4
-----
A 333 CYS22.84-Favored (7.6%)
General / -52.9,148.5
Favored (97.3%) m
chi angles: 290
0.14Å---
A 334 LEU14.62-Favored (11.82%)
General / -100.9,164.4
Favored (20.1%) mt
chi angles: 297.3,160.5
0.09Å---
A 335 GLN52.86-Favored (67.95%)
General / -56.6,-35.2
Favored (24.6%) pt0
chi angles: 63.9,178.8,316.9
0.13Å---
A 336 ASN17.21-Favored (57.23%)
General / -91.0,1.2
Favored (16%) p0
chi angles: 56.9,309.5
0.07Å---
A 337 THR12.17-Favored (12.05%)
General / -118.2,7.3
Favored (25.4%) p
chi angles: 70.9
0.06Å---
A 338 VAL14.29-Favored (90.21%)
Ile or Val / -62.7,-48.0
Favored (34.8%) t
chi angles: 166.1
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 339 ASN11.15-Favored (89.48%)
General / -58.7,-42.9
Favored (51.6%) m-40
chi angles: 295.5,355
0.07Å---
A 340 ASP30.1-Favored (92.19%)
General / -65.3,-39.2
Favored (79.2%) m-30
chi angles: 296.2,333.5
0.10Å---
A 341 PHE14.71-Favored (65.49%)
General / -53.7,-50.6
Favored (61.3%) t80
chi angles: 176.4,270.1
0.06Å---
A 342 TRP11.37-Favored (76.52%)
General / -67.0,-33.9
Favored (74.8%) m100
chi angles: 286.6,115
0.11Å---
A 343 ARG14.1-Favored (84.93%)
General / -58.5,-41.3
Favored (61%) mtp180
chi angles: 282.7,169.1,63.9,205.1
0.04Å---
A 344 MET17.09-Favored (59.63%)
General / -64.5,-52.1
Favored (59.7%) ttp
chi angles: 176.1,179.4,67.3
0.04Å---
A 345 VAL9.63-Favored (61.53%)
Ile or Val / -53.8,-48.4
Favored (75.6%) t
chi angles: 172.7
0.12Å---
A 346 PHE15.96-Favored (73.13%)
General / -64.8,-48.8
Favored (71.9%) t80
chi angles: 184.4,86.7
0.05Å---
A 347 GLN16.72-Favored (89.11%)
General / -64.1,-37.9
Favored (24.1%) tt0
chi angles: 167.3,184.2,291.3
0.02Å---
A 348 GLU23.31-Favored (59.07%)
General / -87.2,-3.6
Favored (77.4%) mm-30
chi angles: 297,294.5,320.9
0.09Å---
A 349 ASN21.31-Favored (12.68%)
General / 65.0,26.8
Favored (60.2%) t0
chi angles: 198.2,30.3
0.09Å---
A 350 SER12.94-Favored (55.62%)
General / -67.9,138.0
Favored (59.9%) m
chi angles: 299
0.03Å---
A 351 ARG15.62-Favored (9.23%)
General / -121.7,-4.7
Favored (26.7%) mmt90
chi angles: 302.2,307.7,182.3,82.2
0.05Å---
A 352 VAL11.25-Favored (34.84%)
Ile or Val / -139.4,131.1
Favored (58.8%) t
chi angles: 180.1
0.04Å---
A 353 ILE12.73-Favored (61.6%)
Ile or Val / -120.0,135.0
Favored (88.5%) mt
chi angles: 298.2,169.9
0.04Å---
A 354 VAL15.51-Favored (46.78%)
Ile or Val / -115.8,114.6
Favored (93.3%) t
chi angles: 174.6
0.04Å---
A 355 MET13.590.44Å
HG3 with A 458 HIS CE1
Favored (45.69%)
General / -109.1,121.7
Favored (28.9%) ttt
chi angles: 177,170.3,178.8
0.05Å---
A 356 THR17.88-Favored (5.74%)
General / -116.6,33.1
Favored (76.6%) p
chi angles: 61.1
0.05Å---
A 357 THR17.32-Favored (42.27%)
General / -143.8,153.3
Favored (6.5%) t
chi angles: 182.1
0.05Å---
A 358 LYS17-Favored (26.34%)
General / -69.0,162.7
Favored (39.1%) mttp
chi angles: 289,185.9,189.4,73.5
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 359 GLU19.35-Favored (91%)
General / -61.3,-39.6
Favored (33.7%) mt-10
chi angles: 290.5,167.1,48.1
0.04Å---
A 360 VAL15.7-Favored (67.1%)
Ile or Val / -129.6,130.6
Favored (67.3%) t
chi angles: 171.8
0.03Å---
A 361 GLU18.18-Favored (45.79%)
General / -133.7,138.2
Favored (93.4%) mt-10
chi angles: 296.9,183,359.4
0.05Å---
A 362 ARG39.47-Favored (18.4%)
General / 51.6,36.9
Favored (10.4%) mmt-90
chi angles: 289.4,265.7,198.1,274.9
0.03Å---
A 363 GLY18.02-Favored (87.19%)
Glycine / 78.0,6.0
-----
A 364 LYS38.22-Favored (51.62%)
General / -119.0,139.5
Allowed (0.5%) mtmp
chi angles: 294.4,179.6,264.1,100.2
0.03Å---
A 365 SER17.77-Favored (18.65%)
General / -69.3,122.3
Favored (32.2%) t
chi angles: 183.3
0.06Å---
A 366 LYS24.61-Favored (13.13%)
General / -104.7,-23.1
Favored (57.6%) mmtt
chi angles: 300.8,296.5,177.8,164.6
0.07Å---
A 367 CYS15.77-Favored (2.87%)
General / -162.9,126.5
Favored (52.7%) t
chi angles: 184.1
0.01Å---
A 368 VAL18.16-Favored (4.08%)
Ile or Val / -76.2,163.1
Favored (28.2%) m
chi angles: 300.9
0.07Å---
A 369 LYS25.34-Favored (9.99%)
General / -77.7,107.2
Favored (32.6%) tttm
chi angles: 182.3,165.1,170.5,286.7
0.09Å---
A 370 TYR13.99-Favored (43.12%)
General / -100.8,8.6
Favored (40.4%) p90
chi angles: 57.1,83
0.04Å---
A 371 TRP14.79-Favored (71.96%)
Pre-Pro / -125.3,154.5
Favored (53.2%) p90
chi angles: 62.3,90.3
0.03Å---
A 372 PRO12.78-Favored (43.03%)
Trans-Pro / -73.3,161.4
Favored (13%) Cg_exo
chi angles: 344.4,28.2,330
0.10Å---
A 373 ASP24.42-Favored (14.63%)
General / -59.2,155.2
Favored (67.3%) m-30
chi angles: 298.4,342.5
0.02Å---
A 374 GLU15.88-Favored (30.98%)
General / -51.9,131.3
Favored (27.1%) tt0
chi angles: 195.5,177.7,31.9
0.04Å---
A 375 TYR23.4-Favored (2.63%)
General / 76.5,-2.9
Favored (23.7%) m-80
chi angles: 309.1,305.3
0.12Å---
A 376 ALA13.05-Favored (14.77%)
General / -92.3,161.2
-0.07Å---
A 377 LEU12.74-Favored (54.97%)
General / -120.2,135.5
Favored (13.3%) tp
chi angles: 180.8,76.1
0.16Å---
A 378 LYS42.86-Favored (48.63%)
General / -136.1,149.3
Favored (6.9%) mtpt
chi angles: 287.5,206,78.6,196.3
0.11Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 379 GLU14.81-Favored (49.83%)
General / -104.0,132.8
Favored (87.3%) mt-10
chi angles: 288.5,177,12.3
0.04Å---
A 380 TYR14.42-Favored (3.85%)
General / -118.4,92.5
Favored (81.7%) m-80
chi angles: 302.8,279.5
0.02Å---
A 381 GLY13.89-Favored (27.49%)
Glycine / 54.9,-122.9
-----
A 382 VAL24.1-Favored (8.47%)
Ile or Val / -84.4,-4.2
Favored (11.5%) m
chi angles: 306.3
0.01Å---
A 383 MET19.48-Favored (37.62%)
General / -103.6,140.4
Favored (26.3%) mmt
chi angles: 297,301.1,164
0.01Å---
A 384 ARG18.26-Favored (55.76%)
General / -115.5,133.7
Favored (31.3%) ttm170
chi angles: 176.3,173.7,288.4,144.7
0.11Å---
A 385 VAL12.66-Favored (46.96%)
Ile or Val / -134.4,125.2
Favored (82.3%) t
chi angles: 177.8
0.01Å---
A 386 ARG26.36-Favored (47.23%)
General / -102.6,133.6
Favored (71.3%) ttm-80
chi angles: 179.6,173.7,303.6,278.1
0.12Å---
A 387 ASN12.17-Favored (15.17%)
General / -91.1,102.4
Favored (54.3%) t0
chi angles: 181.9,342
0.06Å---
A 388 VAL18.670.42Å
HG21 with A 402 LYS HD3
Favored (44.36%)
Ile or Val / -75.2,-43.1
Favored (98.7%) t
chi angles: 175.6
0.07Å---
A 389 LYS25.59-Favored (4.8%)
General / -165.8,140.7
Favored (11.6%) tptp
chi angles: 191.7,75.8,192,72.9
0.05Å---
A 390 GLU25.93-Favored (42.7%)
General / -111.9,143.6
Favored (61.5%) mt-10
chi angles: 302,192.3,352.9
0.06Å---
A 391 SER18.86-Favored (33.95%)
General / -130.3,125.1
Favored (71.4%) m
chi angles: 296
0.06Å---
A 392 ALA25.03-Favored (36.61%)
General / -96.7,136.9
-0.06Å---
A 393 ALA21.45-Favored (3.48%)
General / -124.3,-176.3
-0.05Å---
A 394 HIS39.18-Favored (68.94%)
General / -61.8,-51.3
Favored (83.7%) t70
chi angles: 182.5,78.3
0.06Å---
A 395 ASP26.56-Favored (19.44%)
General / -101.6,-11.2
Favored (20.7%) m-30
chi angles: 283.8,306.7
0.07Å---
A 396 TYR16.22-Favored (42.68%)
General / -152.6,161.4
Favored (45%) p90
chi angles: 71.1,272.7
0.04Å---
A 397 THR16.22-Favored (53.18%)
General / -114.2,136.2
Favored (88.8%) m
chi angles: 298.6
0.05Å---
A 398 LEU15.66-Favored (47.48%)
General / -101.5,129.0
Favored (55.4%) tp
chi angles: 173.3,61.5
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 399 ARG17.23-Favored (34.63%)
General / -117.8,119.3
Favored (53.1%) mtt90
chi angles: 310.1,190.5,176.6,89.6
0.09Å---
A 400 GLU17.26-Favored (18.84%)
General / -86.2,109.4
Favored (82.4%) tt0
chi angles: 177.6,179.4,349.4
0.05Å---
A 401 LEU14.42-Favored (39.9%)
General / -111.1,144.7
Favored (23%) mt
chi angles: 311,175.2
0.04Å---
A 402 LYS32.850.42Å
HD3 with A 388 VAL HG21
Favored (44.17%)
General / -111.7,121.1
Favored (2.3%) mptt
chi angles: 250.5,59,159.5,171.9
0.09Å---
A 403 LEU11.42-Favored (55.23%)
General / -113.1,133.0
Favored (15.6%) tp
chi angles: 165.5,65.8
0.05Å---
A 404 SER12.66-Favored (34.59%)
General / -149.6,164.7
Favored (79%) p
chi angles: 61
0.05Å---
A 405 LYS38.56-Favored (34.69%)
General / -92.2,134.7
Favored (21.9%) tttt
chi angles: 184.3,162.8,176.1,208.8
0.07Å---
A 406 VAL17.18-Favored (19.7%)
Ile or Val / -56.0,134.8
Favored (89.6%) t
chi angles: 174.1
0.07Å---
A 407 GLY17.35-Favored (89.65%)
Glycine / 83.5,-0.4
-----
A 408 GLN42.37-Favored (2.24%)
General / -135.6,86.4
OUTLIER (0.3%)
chi angles: 320,214.7,235.7
0.06Å---
A 409 GLY25.38-Favored (96.53%)
Glycine / -59.7,-40.4
-----
A 410 ASN39.1-Allowed (0.3%)
General / -68.4,9.9
Favored (4.2%) t0
chi angles: 218,29.4
0.07Å---
A 411 THR13.79-Favored (26.83%)
General / -105.7,1.1
Favored (67.8%) p
chi angles: 62.7
0.05Å---
A 412 GLU36.72-Favored (57.38%)
General / -63.2,135.8
Favored (12%) tt0
chi angles: 191.9,160,64.5
0.01Å---
A 413 ARG14.73-Favored (45.61%)
General / -141.5,154.6
Allowed (1.1%) pmm-80
chi angles: 72.8,296.4,311.3,282.1
0.07Å---
A 414 THR13.01-Favored (35.69%)
General / -81.3,135.6
Favored (56.2%) m
chi angles: 303.8
0.07Å---
A 415 VAL14.26-Favored (74.05%)
Ile or Val / -119.8,125.2
Favored (87.8%) t
chi angles: 176.1
0.08Å---
A 416 TRP10.8-Favored (32.27%)
General / -101.1,116.2
Favored (53.4%) m100
chi angles: 305.8,89.2
0.02Å---
A 417 GLN15.79-Favored (29.79%)
General / -102.2,115.1
Favored (10.8%) tt0
chi angles: 186.5,208,36.1
0.03Å---
A 418 TYR13.810.47Å
HB3 with A 438 PHE CE1
Favored (24.66%)
General / -99.0,112.6
Favored (76.1%) m-80
chi angles: 288.5,85
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 419 HIS13.54-Favored (10.66%)
General / -109.3,101.7
Favored (21.3%) t-170
chi angles: 187.1,181.2
0.08Å---
A 420 PHE15.79-Favored (30.45%)
General / -76.1,126.1
Favored (21.9%) t80
chi angles: 197.8,84
0.01Å---
A 421 ARG39.57-Favored (11.52%)
General / -116.8,-5.4
Favored (29.6%) mtm110
chi angles: 287.9,185.4,284.5,89.4
0.02Å---
A 422 THR17.55-Favored (19.66%)
General / -112.5,10.0
Favored (72.3%) p
chi angles: 59.7
0.02Å---
A 423 TRP26.27-Favored (92.65%)
Pre-Pro / -60.6,137.8
Favored (24.7%) t-100
chi angles: 192.2,277.2
0.04Å---
A 424 PRO14.66-Favored (58.46%)
Trans-Pro / -68.2,158.2
Favored (75.8%) Cg_endo
chi angles: 28.1,318.9,38.3
0.06Å---
A 425 ASP17.29-Favored (74.68%)
General / -67.1,-33.1
Favored (94.4%) m-30
chi angles: 290.7,340.9
0.12Å---
A 426 HIS23.53-Favored (46.84%)
General / -127.9,153.3
Favored (9.4%) m-70
chi angles: 294.9,335.8
0.09Å---
A 427 GLY14.63-Favored (44.46%)
Glycine / 75.7,-153.8
-----
A 428 VAL12.71-Favored (45.01%)
Pre-Pro / -133.2,164.3
Favored (26.2%) m
chi angles: 299.6
0.02Å---
A 429 PRO15.48-Favored (95.48%)
Trans-Pro / -61.6,142.8
Favored (71.6%) Cg_exo
chi angles: 335.2,37.6,323.6
0.09Å---
A 430 SER28.74-Favored (65.84%)
General / -67.5,-25.4
Favored (76.2%) p
chi angles: 70.9
0.06Å---
A 431 ASP38.41-Favored (22.7%)
Pre-Pro / -134.5,134.7
Favored (16.7%) t70
chi angles: 190.5,86.3
0.06Å---
A 432 PRO17.44-Favored (10.5%)
Trans-Pro / -83.9,-6.2
Favored (28.7%) Cg_endo
chi angles: 35.4,319.6,29.9
0.03Å---
A 433 GLY16.74-Favored (79.23%)
Glycine / -54.6,-44.7
-----
A 434 GLY16.86-Favored (55.22%)
Glycine / -61.0,-52.0
-----
A 435 VAL18.01-Favored (81.16%)
Ile or Val / -57.0,-43.4
Favored (36.5%) t
chi angles: 166.6
0.08Å---
A 436 LEU17.06-Favored (83.92%)
General / -67.8,-40.3
Favored (48.4%) mt
chi angles: 284.9,172.6
0.04Å---
A 437 ASP33.86-Favored (94.89%)
General / -63.8,-39.7
Favored (80.2%) m-30
chi angles: 293.1,351.5
0.08Å---
A 438 PHE14.10.47Å
CE1 with A 418 TYR HB3
Favored (67.21%)
General / -63.2,-51.2
Favored (66.6%) t80
chi angles: 171.4,83.9
0.07Å- OUTLIER(S)
worst is CA-CB-CG: 4.1 σ
-
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 439 LEU26.59-Favored (73.5%)
General / -64.1,-32.1
Favored (10.9%) mt
chi angles: 281.9,182.6
0.04Å---
A 440 GLU22.61-Favored (90.18%)
General / -61.3,-46.5
Favored (17.1%) tp30
chi angles: 198.5,74.2,4.9
0.06Å---
A 441 GLU24.62-Favored (81.11%)
General / -66.8,-44.4
Favored (67.5%) tp30
chi angles: 181.6,69.2,17.7
0.04Å---
A 442 VAL15.08-Favored (71.43%)
Ile or Val / -54.5,-47.0
Favored (61%) t
chi angles: 170.9
0.02Å---
A 443 HIS16.74-Favored (68.95%)
General / -56.7,-51.4
Favored (86.7%) t70
chi angles: 177.1,78
0.03Å---
A 444 HIS30.85-Favored (88.25%)
General / -64.6,-37.6
Favored (28.5%) m-70
chi angles: 286.7,313.6
0.06Å---
A 445 LYS10.47-Favored (63.87%)
General / -59.5,-52.8
Favored (19.5%) tppt
chi angles: 182.3,63.1,67.4,174.5
0.05Å---
A 446 GLN12.81-Favored (80.14%)
General / -57.6,-48.2
Favored (19.6%) tp40
chi angles: 171,77.5,1.9
0.09Å---
A 447 GLU29.62-Favored (69.34%)
General / -59.9,-30.9
Favored (86%) tt0
chi angles: 187.3,178.3,8.7
0.07Å---
A 448 SER10-Favored (58.21%)
General / -74.9,-9.1
Favored (48%) p
chi angles: 75.2
0.04Å---
A 449 ILE14.54-Favored (48.53%)
Ile or Val / -109.7,115.0
Favored (77.7%) mt
chi angles: 300.7,170.4
0.07Å---
A 450 MET50.42-Favored (32.43%)
General / -64.8,127.6
Favored (45%) tpp
chi angles: 186.9,52.1,71.5
0.06Å---
A 451 ASP40.78-Favored (14.25%)
General / 61.4,24.1
Favored (66.3%) m-30
chi angles: 294.4,311.9
0.08Å---
A 452 ALA13.99-Favored (24.61%)
General / -53.3,141.3
-0.04Å---
A 453 GLY12.46-Favored (35.73%)
Glycine / -79.0,-168.8
-----
A 454 PRO15.22-Favored (74.75%)
Trans-Pro / -59.7,150.7
Favored (3.9%) Cg_exo
chi angles: 353.3,9.7,350.9
0.13Å---
A 455 VAL11.58-Favored (38.98%)
Ile or Val / -79.1,126.4
Favored (65.3%) t
chi angles: 171.5
0.04Å---
A 456 VAL13.99-Favored (35.78%)
Ile or Val / -86.4,131.0
Favored (40.9%) t
chi angles: 167.8
0.04Å---
A 457 VAL12.2-Favored (63.82%)
Ile or Val / -130.6,128.8
Favored (19.6%) t
chi angles: 187
0.02Å---
A 458 HIS15.510.44Å
CE1 with A 355 MET HG3
Favored (42.02%)
General / -147.1,155.2
Favored (25.6%) p90
chi angles: 74.1,84.8
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 459 CYS18.27-Allowed (0.23%)
General / -127.3,-126.1
Favored (5.5%) p
chi angles: 50.3
0.16Å---
A 460 SER16.89-Allowed (0.37%)
General / -88.1,-77.0
Favored (51.1%) p
chi angles: 56.5
0.03Å---
A 461 ALA14.1-Favored (39.5%)
General / -81.0,-22.2
-0.06Å---
A 462 GLY11.05-Favored (33.26%)
Glycine / 83.0,29.8
-----
A 463 ILE13.44-Allowed (0.46%)
Ile or Val / -134.0,-36.2
Favored (25.3%) pt
chi angles: 62.7,180.4
0.10Å---
A 464 GLY10.69-Allowed (1.32%)
Glycine / -85.3,-71.1
-- OUTLIER(S)
worst is N--CA: 4.3 σ
--
A 465 ARG12.78-Favored (97.39%)
General / -64.0,-42.2
Favored (81.1%) mtt180
chi angles: 296.5,177.1,197,176.4
0.03Å---
A 466 THR12.41-Favored (76.04%)
General / -56.7,-49.2
Favored (20%) m
chi angles: 290.5
0.05Å---
A 467 GLY10.71-Favored (89.34%)
Glycine / -65.5,-34.5
-----
A 468 THR12.38-Favored (71.25%)
General / -66.5,-48.0
Favored (92.4%) m
chi angles: 299.1
0.04Å---
A 469 PHE22.2-Favored (97.33%)
General / -62.8,-44.0
Favored (22%) m-80
chi angles: 276.1,73.4
0.05Å---
A 470 ILE10.99-Favored (93.39%)
Ile or Val / -62.2,-47.4
Favored (71.7%) mt
chi angles: 288.2,167.6
0.13Å---
A 471 VAL10.83-Favored (99.49%)
Ile or Val / -62.3,-44.7
Favored (38.3%) t
chi angles: 167.1
0.12Å---
A 472 ILE13.2-Favored (85.18%)
Ile or Val / -57.9,-43.9
Favored (93.2%) mt
chi angles: 291.9,169.5
0.07Å---
A 473 ASP15.7-Favored (99.69%)
General / -62.9,-42.1
Favored (20.9%) t70
chi angles: 194.9,60.2
0.09Å---
A 474 ILE10.88-Favored (97.35%)
Ile or Val / -62.8,-46.0
Favored (94%) mt
chi angles: 292.4,166
0.07Å---
A 475 LEU14.32-Favored (75.49%)
General / -69.9,-40.7
Favored (62.9%) mt
chi angles: 296.5,167.1
0.03Å---
A 476 ILE20.50.45Å
O with A 480 ARG HG3
Favored (58.92%)
Ile or Val / -67.8,-33.0
Favored (84.9%) mt
chi angles: 293.3,163.8
0.08Å---
A 477 ASP29.8-Favored (82.48%)
General / -62.4,-36.5
Favored (20.8%) t70
chi angles: 195.9,51.2
0.10Å---
A 478 ILE18.51-Favored (95.58%)
Ile or Val / -60.6,-46.4
Favored (82.8%) mt
chi angles: 296.3,165
0.13Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 479 ILE18.82-Favored (69.37%)
Ile or Val / -69.5,-36.0
Favored (17.3%) mt
chi angles: 298.8,152.8
0.10Å---
A 480 ARG24.20.45Å
HG3 with A 476 ILE O
Favored (96.77%)
General / -62.7,-44.2
Favored (58.2%) mtt-85
chi angles: 303.3,174,183,293.9
0.31Å- OUTLIER(S)
worst is C-CA-CB: 6.2 σ
-
A 481 GLU61.85-Favored (14.58%)
General / -76.8,-50.0
Favored (3.3%) tt0
chi angles: 197.5,203,45.6
0.08Å---
A 482 LYS45.58-Favored (32.8%)
General / -95.6,-9.3
Favored (59.5%) mttt
chi angles: 286,185.8,199.4,184.1
0.05Å---
A 483 GLY21.59-Favored (52.05%)
Glycine / 79.7,179.1
-----
A 484 VAL29.37-Favored (18.15%)
Ile or Val / -71.6,-15.1
OUTLIER (0.2%)
chi angles: 320.3
0.10Å---
A 485 ASP33.73-Favored (5.07%)
General / -91.8,65.8
Favored (82.4%) m-30
chi angles: 293.2,330.4
0.08Å---
A 486 CYS22.07-Favored (45.07%)
General / -135.5,158.2
Favored (28.9%) p
chi angles: 67
0.03Å---
A 487 ASP34.96-Favored (34.17%)
General / -93.5,136.0
Favored (67.9%) m-30
chi angles: 279.8,346.1
0.10Å---
A 488 ILE24.41-Favored (47.94%)
Ile or Val / -131.2,140.7
Favored (26.7%) pt
chi angles: 55.9,166.5
0.09Å---
A 489 ASP14.77-Favored (3.84%)
General / -134.9,97.8
Favored (55.4%) t0
chi angles: 190,340.2
0.04Å---
A 490 VAL11.27-Favored (62.78%)
Pre-Pro / -62.4,-52.9
Favored (49.6%) t
chi angles: 169.3
0.07Å---
A 491 PRO10.59-Favored (73.86%)
Trans-Pro / -63.3,-31.7
Favored (33.3%) Cg_endo
chi angles: 22,328.3,29.6
0.07Å---
A 492 LYS31.43-Favored (88.85%)
General / -62.9,-46.2
Favored (71%) tttt
chi angles: 186.6,170,176.5,191.8
0.08Å---
A 493 THR11.95-Favored (94.09%)
General / -59.9,-44.8
Favored (84%) m
chi angles: 301.9
0.12Å---
A 494 ILE12.58-Favored (90.28%)
Ile or Val / -66.6,-43.9
Favored (92.6%) mt
chi angles: 296.3,172.3
0.08Å---
A 495 GLN14.21-Favored (76.49%)
General / -60.5,-35.7
Favored (15.6%) tp40
chi angles: 185.3,74.8,347.3
0.03Å---
A 496 MET23.42-Favored (89.22%)
General / -65.8,-43.3
Favored (12.6%) tmm
chi angles: 180.8,265.8,302.4
0.05Å---
A 497 VAL17.57-Favored (80.45%)
Ile or Val / -69.4,-40.8
Favored (43.8%) t
chi angles: 168.5
0.11Å---
A 498 ARG13.29-Favored (65.25%)
General / -63.4,-20.1
Favored (94.7%) mtt180
chi angles: 289.2,180.9,172.5,181.6
0.09Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 499 ASER13.26-Favored (55.67%)
General / -74.7,-8.2
Favored (33.3%) p
chi angles: 77
0.04Å---
A 499 BSER13.26-Favored (57.32%)
General / -74.3,-8.8
Favored (11.3%) m
chi angles: 307.6
0.03Å---
A 500 GLN13.04-Favored (10.29%)
General / -115.7,-20.1
Favored (54.8%) mt0
chi angles: 298.5,176.7,81
0.02Å---
A 501 ARG13.2-Favored (19.63%)
General / -153.5,140.8
Favored (54.2%) ttt90
chi angles: 182.1,167.3,171,85.7
0.04Å---
A 502 SER15.48-Favored (49.86%)
General / -57.9,131.2
Favored (67%) m
chi angles: 294.5
0.10Å---
A 503 GLY12.35-Favored (74.53%)
Glycine / 69.5,19.3
-----
A 504 MET15.35-Favored (27.55%)
General / -59.1,126.4
Favored (54%) mmm
chi angles: 297.3,285,274.5
0.03Å---
A 505 VAL11.19-OUTLIER (0.04)%)
Ile or Val / 70.9,109.4
Favored (14.3%) t
chi angles: 188.4
0.13Å---
A 506 GLN13.72-Favored (13.37%)
General / -91.7,-36.9
Favored (43.9%) mm-40
chi angles: 283.9,284.3,296.6
0.07Å---
A 507 THR12.75-Favored (38.95%)
General / -134.6,160.2
Favored (79.4%) p
chi angles: 60.4
0.07Å---
A 508 GLU33.510.40Å
OE2 with A 512 ARG NH2
Favored (74.42%)
General / -63.9,-32.8
Allowed (0.3%) tm-30
chi angles: 189.8,254.3,32.7
0.08Å---
A 509 ALA13.28-Favored (97.89%)
General / -63.2,-40.6
-0.06Å---
A 510 GLN13.19-Favored (81.63%)
General / -68.0,-41.8
Favored (87.2%) mt0
chi angles: 292.1,164.4,346.7
0.04Å---
A 511 TYR11.93-Favored (75.62%)
General / -56.0,-48.6
Favored (38.2%) t80
chi angles: 192.6,75.7
0.03Å---
A 512 ARG46.80.40Å
NH2 with A 508 GLU OE2
Favored (93.15%)
General / -64.5,-39.1
Favored (45.7%) ttm110
chi angles: 181.5,186.4,293,115.3
0.05Å---
A 513 PHE11.52-Favored (84.82%)
General / -62.5,-37.1
Favored (87.5%) t80
chi angles: 180.5,80.2
0.05Å---
A 514 ILE10.06-Favored (95.23%)
Ile or Val / -60.6,-46.7
Favored (83.9%) mt
chi angles: 292.6,163
0.10Å---
A 515 TYR11.53-Favored (99.68%)
General / -62.6,-42.6
Favored (6%) m-80
chi angles: 267.6,275.4
0.01Å---
A 516 MET33.220.73Å
HE1 with A 230 VAL CG1
Favored (92.63%)
General / -63.0,-38.8
Favored (11.9%) mmp
chi angles: 289.4,317.8,88.5
0.04Å---
A 517 ALA14.82-Favored (78.75%)
General / -67.5,-44.3
-0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 518 VAL19.67-Favored (88.08%)
Ile or Val / -58.6,-47.6
Favored (48%) t
chi angles: 169.1
0.07Å---
A 519 GLN30.81-Favored (76.61%)
General / -55.4,-46.3
Favored (9.5%) tt0
chi angles: 179.3,180.2,227
0.05Å---
A 520 HIS35.77-Favored (84.18%)
General / -67.6,-38.7
Favored (76.1%) t-90
chi angles: 188.9,281.4
0.09Å---
A 521 TYR22.55-Favored (88.34%)
General / -64.3,-45.4
Favored (85.1%) t80
chi angles: 180.4,83.2
0.06Å---
A 522 ILE21.75-Favored (81.04%)
Ile or Val / -67.0,-38.3
Favored (37.1%) mt
chi angles: 289.3,156.9
0.09Å---
A 523 GLU46.97-Favored (69.13%)
General / -59.8,-30.7
OUTLIER (0%)
chi angles: 249,246.8,310.5
0.06Å---
A 524 THR37.67-Favored (32.76%)
General / -103.3,13.9
Favored (68.8%) p
chi angles: 59
0.10Å---
A 525 LEU48.79--Favored (12.5%) mt
chi angles: 283.1,182.5
0.02Å---
B 4 ARG18.2--Favored (36.4%) ttt-90
chi angles: 200,167.1,178.5,270.2
0.02Å---
B 5 ARG32.94-Favored (53.64%)
General / -78.1,-6.1
Favored (49.1%) mtp180
chi angles: 301.8,198.9,65.3,181.1
0.05Å---
B 6 TRP12.640.53Å
HB3 with B 101 PRO HB3
Favored (56.22%)
General / -76.3,-8.0
Favored (19.2%) p-90
chi angles: 41.7,258.7
0.06Å---
B 7 PHE15.33-Favored (30.95%)
General / -91.8,118.7
Favored (46%) t80
chi angles: 191.5,85.2
0.10Å---
B 8 HIS14.04-Favored (60.84%)
Pre-Pro / -109.0,108.8
Favored (9.2%) m-70
chi angles: 296.9,231.5
0.04Å---
B 9 PRO16.54-Favored (16.64%)
Trans-Pro / -75.6,-19.5
Favored (35.9%) Cg_endo
chi angles: 22.5,326.8,31.3
0.12Å---
B 10 ASN29.87-Favored (8.81%)
General / -123.8,5.1
Favored (58.9%) m-40
chi angles: 282.4,313.8
0.04Å---
B 11 ILE23.970.47Å
CD1 with B 19 LEU HD22
Favored (4.3%)
Ile or Val / -92.8,149.1
Favored (8.8%) tt
chi angles: 201.6,164.1
0.11Å---
B 12 THR18.02-Favored (14.29%)
General / -87.7,167.0
Favored (28.6%) p
chi angles: 69.8
0.03Å---
B 13 GLY16.11-Favored (87.43%)
Glycine / -56.3,-41.6
-----
B 14 VAL22.14-Favored (90.32%)
Ile or Val / -66.0,-41.7
Favored (56.3%) t
chi angles: 170.3
0.04Å---
B 15 GLU24.11-Favored (94.57%)
General / -64.7,-40.0
Favored (74.6%) mt-10
chi angles: 285.3,162,344.4
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 16 ALA13.51-Favored (88.57%)
General / -60.8,-46.9
-0.03Å---
B 17 GLU25.8-Favored (80.54%)
General / -58.6,-48.6
Favored (69.3%) mt-10
chi angles: 284.7,178.8,22.1
0.10Å---
B 18 ASN33.1-Favored (90.73%)
General / -65.8,-39.1
Favored (98.3%) m-40
chi angles: 291.9,339
0.10Å---
B 19 LEU27.390.47Å
HD22 with B 11 ILE CD1
Favored (82.21%)
General / -60.5,-48.3
Allowed (0.6%) tp
chi angles: 226.5,48.8
0.05Å---
B 20 LEU15.85-Favored (76.64%)
General / -67.0,-34.0
Favored (57.3%) mt
chi angles: 286.7,164.7
0.01Å---
B 21 LEU19.07-Favored (35.5%)
General / -80.9,-29.4
Favored (81.7%) mt
chi angles: 290.5,174.2
0.02Å---
B 22 THR15.6-Favored (13.92%)
General / -101.2,-25.6
Favored (45.6%) p
chi angles: 66.4
0.07Å---
B 23 ARG41.75-Favored (7.43%)
General / -124.6,-8.0
Favored (6.4%) mtp-110
chi angles: 280.9,199.9,46.4,247.8
0.02Å---
B 24 GLY11.91-Favored (21.31%)
Glycine / -108.9,-173.8
-----
B 25 VAL11.99-Favored (7.38%)
Ile or Val / -138.2,176.1
Favored (31.3%) m
chi angles: 297
0.05Å---
B 26 ASP18.09-Favored (20.07%)
General / -56.2,125.1
Favored (95.1%) m-30
chi angles: 288.2,350.2
0.05Å---
B 27 GLY10.62-Favored (58.33%)
Glycine / 100.2,-7.2
-----
B 28 SER10.20.43Å
HA with B 100 TYR O
Favored (47.38%)
General / -71.5,147.9
Favored (70.7%) m
chi angles: 295.1
0.06Å---
B 29 PHE11.15-Favored (43.04%)
General / -152.9,160.5
Favored (43.7%) p90
chi angles: 70.3,89.9
0.04Å---
B 30 LEU11.540.40Å
C with B 30 LEU HD12
Favored (29.57%)
General / -149.1,166.2
Favored (2.7%) pp
chi angles: 59.7,77.6
0.03Å---
B 31 ALA11.85-Favored (33.7%)
General / -122.4,156.6
-0.04Å---
B 32 ARG13.83-Favored (15.98%)
Pre-Pro / -160.4,166.3
Favored (43.9%) ptt90
chi angles: 59.8,189.2,174.2,80.5
0.09Å---
B 33 PRO15.84-Favored (86.35%)
Trans-Pro / -65.7,147.8
Favored (29.2%) Cg_exo
chi angles: 340.2,31.8,328.8
0.09Å---
B 34 SER15.33-Favored (38.55%)
General / -77.5,133.7
Favored (24.9%) t
chi angles: 171.5
0.04Å---
B 35 LYS36.92-Favored (17.8%)
General / -90.0,-30.3
Favored (12.7%) mmtt
chi angles: 300.7,285.6,210.3,203.3
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 36 SER18.55-Favored (46.7%)
General / -78.4,-27.1
Favored (86%) p
chi angles: 69.7
0.06Å---
B 37 ASN36.78-Favored (32.37%)
Pre-Pro / -136.2,83.5
Favored (22.9%) t0
chi angles: 204.9,49.9
0.07Å---
B 38 PRO27.55-Favored (42.67%)
Trans-Pro / -53.1,131.4
Favored (58.5%) Cg_exo
chi angles: 328.3,40,326.6
0.03Å---
B 39 GLY22.31-Favored (19.99%)
Glycine / 109.3,-24.7
-----
B 40 ASP28.44-Favored (9.06%)
General / -94.6,171.0
Favored (98.5%) m-30
chi angles: 288.1,348
0.04Å---
B 41 PHE16.74-Favored (17.22%)
General / -131.6,168.7
Favored (92.4%) m-80
chi angles: 299.7,271.7
0.04Å---
B 42 THR15.62-Favored (30.87%)
General / -139.0,132.8
Favored (66.7%) m
chi angles: 303.2
0.01Å---
B 43 LEU15.42-Favored (27.48%)
General / -99.6,114.4
Favored (67.1%) tp
chi angles: 178.2,58.8
0.13Å---
B 44 SER13.12-Favored (45.75%)
General / -104.6,122.5
Favored (21.3%) m
chi angles: 304.4
0.06Å---
B 45 VAL14.08-Favored (57.74%)
Ile or Val / -133.1,134.6
Favored (42.8%) t
chi angles: 182.9
0.01Å---
B 46 ARG15.34-Favored (37.81%)
General / -92.0,130.2
Favored (45.7%) ttt180
chi angles: 177.4,162.3,162.3,172.6
0.04Å---
B 47 ARG31.690.50Å
HD2 with B 96 ILE HD11
Favored (21.35%)
General / -151.2,140.5
Allowed (1.4%) pmt-80
chi angles: 78.2,286.3,192.4,259.7
0.08Å---
B 48 ASN33.17-Favored (30.63%)
General / 53.6,39.8
Favored (78.1%) m-40
chi angles: 301.2,307.2
0.05Å---
B 49 GLY16.79-Favored (62.59%)
Glycine / 67.2,13.6
-----
B 50 ALA16.64-Favored (17.87%)
General / -128.7,167.0
-0.06Å---
B 51 VAL15.54-Favored (64.02%)
Ile or Val / -114.1,132.1
Favored (70.3%) t
chi angles: 172.1
0.03Å---
B 52 THR22.41-Favored (40.56%)
General / -110.4,143.5
Favored (12.8%) t
chi angles: 187.7
0.09Å---
B 53 HIS13.99-Favored (27.59%)
General / -116.4,116.4
Favored (93.7%) m-70
chi angles: 298.6,278.4
0.10Å---
B 54 ILE19.63-Favored (68.89%)
Ile or Val / -111.5,126.9
Favored (57.4%) mt
chi angles: 305.8,172.1
0.04Å---
B 55 LYS33.82-Favored (44.54%)
General / -74.7,142.3
Favored (26.8%) ttpt
chi angles: 172.9,161.3,65,185.7
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 56 ILE16.18-Favored (54.93%)
Ile or Val / -124.5,118.9
Favored (53.3%) mt
chi angles: 304.5,166.4
0.04Å---
B 57 GLN35.37-Favored (26.87%)
General / -98.6,145.4
Favored (47%) mt0
chi angles: 294.8,182.3,268.4
0.07Å---
B 58 ASN16.49-Favored (4.5%)
General / -144.8,107.7
Favored (37.3%) t0
chi angles: 194.6,328.8
0.04Å---
B 59 THR24.19-Favored (56.67%)
General / -93.6,1.5
Favored (56.6%) p
chi angles: 64.7
0.04Å---
B 60 GLY12.18-Favored (4.03%)
Glycine / 136.6,-10.8
-----
B 61 ASP15.73-Favored (8.73%)
General / -111.1,-27.5
Favored (43.7%) m-30
chi angles: 305.6,313.2
0.08Å---
B 62 TYR19.33-Allowed (1.8%)
General / -177.8,163.2
Favored (2.1%) p90
chi angles: 44,66.7
0.05Å---
B 63 TYR18.82-Favored (25.08%)
General / -85.6,118.4
Favored (94.4%) m-80
chi angles: 295.2,86.6
0.03Å---
B 64 ASP20.88-Favored (11.07%)
General / -110.6,102.5
Favored (64.5%) t0
chi angles: 180.8,355.2
0.05Å- OUTLIER(S)
worst is CA-CB-CG: 4.5 σ
-
B 65 LEU16.86-Favored (28.7%)
General / -83.3,122.6
Favored (30.7%) tp
chi angles: 175.5,70
0.06Å---
B 66 TYR30.91-Favored (24.26%)
General / -62.2,125.5
Favored (31.4%) t80
chi angles: 193.1,69.3
0.07Å---
B 67 GLY22-Favored (84.3%)
Glycine / 75.3,9.0
-----
B 68 GLY19.95-Favored (5.44%)
Glycine / -132.6,-145.4
-----
B 69 GLU40.89-Favored (3.83%)
General / -113.6,179.9
Favored (10.4%) mm-30
chi angles: 304,266.3,11.8
0.03Å---
B 70 LYS26.79-Favored (49.58%)
General / -104.7,133.4
Favored (21%) mttt
chi angles: 292.9,170,175.7,144.1
0.05Å---
B 71 PHE13.53-Favored (43.96%)
General / -130.3,156.8
Favored (85.7%) m-80
chi angles: 290.4,276.1
0.04Å---
B 72 ALA11.98-Favored (31.45%)
General / -82.5,-28.0
-0.09Å---
B 73 THR13.45-Favored (43.38%)
General / -150.2,157.7
Favored (16.2%) p
chi angles: 74.2
0.07Å---
B 74 LEU13.33-Favored (75.92%)
General / -62.5,-34.0
Favored (52.4%) mt
chi angles: 292.5,181.7
0.02Å---
B 75 ALA10.54-Favored (95.65%)
General / -64.7,-42.1
-0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 76 GLU16.81-Favored (76.59%)
General / -66.6,-33.9
Favored (69.6%) mt-10
chi angles: 287,190.2,2.8
0.07Å---
B 77 LEU14.4-Favored (65.6%)
General / -62.9,-51.8
Favored (7.7%) tt
chi angles: 182.5,152.9
0.09Å---
B 78 VAL12.38-Favored (80.17%)
Ile or Val / -68.3,-39.0
Favored (34.9%) t
chi angles: 166.1
0.09Å---
B 79 GLN25.59-Favored (94.95%)
General / -60.1,-44.1
Favored (47.3%) tt0
chi angles: 173.7,176.3,53.3
0.03Å---
B 80 TYR37.51-Favored (76.65%)
General / -60.9,-49.6
Favored (75.3%) t80
chi angles: 175.3,85.4
0.02Å---
B 81 TYR18.61-Favored (53.52%)
General / -77.3,-28.4
Favored (57.1%) m-80
chi angles: 291.2,294.2
0.06Å---
B 82 MET25.11-Favored (68.84%)
General / -69.8,-31.1
Favored (37.3%) mtp
chi angles: 280.8,193.1,73.7
0.03Å---
B 83 GLU50.56--Favored (12%) tt0
chi angles: 183.8,198.2,78.3
0.08Å---
B 96 ILE30.170.50Å
HD11 with B 47 ARG HD2
-OUTLIER (0.1%)
chi angles: 196.1,105.1
0.09Å---
B 97 GLU40.040.55Å
OE1 with B 99 LYS HD2
Favored (50.74%)
General / -103.3,130.9
Favored (53.6%) mt-10
chi angles: 284.8,192.9,346.7
0.04Å---
B 98 LEU17.53-Favored (7.03%)
General / -99.3,95.4
Favored (9.4%) mt
chi angles: 297.1,196.3
0.04Å---
B 99 LYS42.430.55Å
HD2 with B 97 GLU OE1
Favored (4.19%)
General / -107.4,-45.0
Favored (18.8%) mtpp
chi angles: 286,162.6,71.2,68.4
0.07Å---
B 100 TYR11.660.43Å
O with B 28 SER HA
Favored (19.74%)
Pre-Pro / -128.2,107.0
Favored (58.2%) m-80
chi angles: 305.4,289.1
0.07Å---
B 101 PRO16.590.53Å
HB3 with B 6 TRP HB3
Favored (78.78%)
Trans-Pro / -58.8,137.2
Favored (2.8%) Cg_exo
chi angles: 356.2,4.8,355.9
0.14Å- OUTLIER(S)
worst is N-CA-CB: 4.8 σ
-
B 102 LEU18.75-Favored (25.32%)
General / -101.7,112.7
Favored (5.8%) tt
chi angles: 191.1,153.7
0.03Å---
B 103 ASN18.8-Favored (36.39%)
General / -80.7,138.3
Favored (92.9%) m-40
chi angles: 293.7,333.2
0.07Å---
B 104 CYS18.76-Favored (31.85%)
General / -88.0,138.0
Favored (46%) t
chi angles: 177.9
0.07Å---
B 105 ALA22.28-Favored (28.56%)
General / -104.5,0.2
-0.05Å---
B 106 ASP30.920.54Å
OD1 with B 108 THR HG23
Favored (86.59%)
Pre-Pro / -76.0,126.7
Favored (41%) t0
chi angles: 176.2,348.5
0.11Å- OUTLIER(S)
worst is CA-CB-CG: 5.4 σ
-
B 107 PRO16.93-Favored (6.27%)
Trans-Pro / -86.1,4.9
Favored (31.1%) Cg_endo
chi angles: 35,320.8,28.1
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 108 THR37.440.54Å
HG23 with B 106 ASP OD1
Favored (68.76%)
General / -64.2,-27.0
Favored (10.9%) p
chi angles: 46.8
0.03Å---
B 109 SER19.84-Favored (36.81%)
General / -103.0,11.8
Favored (52.3%) m
chi angles: 291.9
0.05Å---
B 110 GLU21.42-Favored (35%)
General / -80.4,141.8
Favored (38.7%) mm-30
chi angles: 296.7,281.9,10.9
0.07Å---
B 111 AARG20.96-Favored (70.11%)
General / -58.7,-33.4
Allowed (1%) mmm160
chi angles: 303.4,249.4,295.7,120.6
0.12Å---
B 111 BARG16.19-Favored (70.4%)
General / -62.8,-29.1
Favored (17.3%) mtm180
chi angles: 279.9,185.9,309.8,145.4
0.05Å---
B 112 TRP10.44-Favored (45.23%)
General / -97.0,-1.6
Favored (14.4%) p-90
chi angles: 40.2,257.5
0.02Å---
B 113 PHE16.94-Favored (44.15%)
General / -98.9,125.0
Favored (62%) t80
chi angles: 184.3,68
0.03Å---
B 114 HIS33.14-Favored (4.03%)
General / -123.8,39.2
Favored (72.1%) m-70
chi angles: 291.4,265.1
0.05Å---
B 115 GLY29.02-OUTLIER (0.01)%)
Glycine / 10.4,-105.1
-----
B 116 HIS53.94-Favored (17.62%)
General / -87.1,106.1
Favored (11.6%) t-170
chi angles: 189.7,219.2
0.09Å---
B 117 LEU37.96-Favored (4.1%)
General / -159.2,124.2
Favored (13.7%) tp
chi angles: 176.4,75.4
0.08Å---
B 118 SER25.550.41Å
OG with B 121 GLU HG2
Favored (29.08%)
General / -75.5,161.6
Favored (2.8%) p
chi angles: 43.6
0.02Å---
B 119 GLY35.54-Favored (78.55%)
Glycine / -63.1,-30.8
-----
B 120 LYS36.53-Favored (26.22%)
General / -71.5,-51.0
Favored (3.6%) mttp
chi angles: 299.6,223.5,175.8,71
0.05Å---
B 121 GLU66.780.41Å
HG2 with B 118 SER OG
Favored (73.1%)
General / -68.5,-32.8
Favored (6.5%) pt0
chi angles: 58.3,193.1,311.3
0.18Å---
B 122 ALA25.81-Favored (86.53%)
General / -58.6,-41.7
-0.02Å---
B 123 GLU27.54-Favored (79.89%)
General / -67.8,-36.2
Allowed (0.4%) mt-10
chi angles: 250.7,198.5,37
0.07Å---
B 124 LYS28.9-Favored (72.77%)
General / -62.2,-50.2
Favored (14.7%) tptt
chi angles: 185.2,75.1,152.2,192.2
0.04Å---
B 125 LEU32.260.49Å
HB3 with B 216 LEU HD21
Favored (90.32%)
General / -66.2,-41.3
Favored (78.6%) mt
chi angles: 290.7,166.7
0.05Å---
B 126 LEU16.85-Favored (74.08%)
General / -69.2,-33.9
Favored (34.4%) mt
chi angles: 282.5,167.4
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 127 THR33.05-Favored (73.83%)
General / -68.4,-45.0
Favored (35.6%) m
chi angles: 293.3
0.01Å---
B 128 GLU38.1-Favored (18.56%)
General / -87.5,-34.7
Favored (95.3%) mt-10
chi angles: 294.1,177.1,340.5
0.03Å---
B 129 LYS43.5-Favored (12.45%)
General / -114.1,-13.1
Favored (5.2%) mttt
chi angles: 304.3,156.3,150.7,201.3
0.04Å---
B 130 GLY20.39-Favored (38.45%)
Glycine / -86.5,166.8
-----
B 131 LYS39.52-Favored (3.29%)
General / -138.1,-172.5
Favored (7.6%) pttp
chi angles: 53.3,188,195.9,66.4
0.06Å---
B 132 HIS22.85-Favored (36.26%)
General / -58.4,128.3
Favored (74.2%) t70
chi angles: 172.1,79.7
0.04Å---
B 133 GLY12.82-Favored (86.64%)
Glycine / 85.1,4.5
-----
B 134 SER12.66-Favored (43.13%)
General / -72.5,131.9
Favored (19.1%) m
chi angles: 287.2
0.03Å---
B 135 PHE9.83-Favored (29.23%)
General / -142.2,164.8
Favored (28.3%) p90
chi angles: 70,282.3
0.05Å---
B 136 LEU13.43-Favored (42.9%)
General / -153.0,159.8
Favored (3.7%) pp
chi angles: 59.5,83.6
0.02Å---
B 137 VAL10.85-Favored (54.59%)
Ile or Val / -121.7,137.7
Favored (71.1%) t
chi angles: 178.6
0.04Å---
B 138 ARG16.59-Favored (41.77%)
General / -138.2,159.5
Favored (33.5%) ptt90
chi angles: 58.3,183.8,190.3,76.2
0.06Å---
B 139 GLU38.84-Favored (43.43%)
General / -74.4,145.8
Favored (42.7%) mt-10
chi angles: 292.3,162.1,30.1
0.07Å---
B 140 SER20.23--Favored (41.4%) t
chi angles: 176.2
0.01Å---
B 142 SER38.310.45Å
N with B 603 PO4 O3
-Favored (90.1%) p
chi angles: 68.4
0.06Å---
B 143 HIS54.84-Allowed (1.36%)
Pre-Pro / -102.4,88.3
Favored (24.4%) m170
chi angles: 299.8,134.6
0.01Å---
B 144 PRO37.14-Favored (20.74%)
Trans-Pro / -70.5,131.8
Favored (8.1%) Cg_exo
chi angles: 348.3,30.4,321.8
0.10Å---
B 145 GLY28.46-Favored (44.03%)
Glycine / 100.7,-21.4
-----
B 146 ASP21.58-Favored (9.03%)
General / -87.4,173.6
Favored (24.9%) m-30
chi angles: 291.4,7.6
0.02Å---
B 147 PHE14.91-Favored (19.59%)
General / -139.2,168.6
Favored (98.1%) m-80
chi angles: 295,271.5
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 148 VAL11.78-Favored (57.4%)
Ile or Val / -132.9,128.9
Favored (47.8%) t
chi angles: 181.9
0.03Å---
B 149 LEU16.01-Favored (40.36%)
General / -98.4,121.4
Favored (11%) tp
chi angles: 164.4,69.6
0.07Å---
B 150 SER13.13-Favored (56.03%)
General / -116.8,129.3
Favored (65.9%) m
chi angles: 297.1
0.04Å---
B 151 VAL20.39-Favored (53.67%)
Ile or Val / -134.2,136.1
Favored (7.1%) t
chi angles: 190.9
0.04Å---
B 152 ARG19.54-Favored (39.47%)
General / -94.8,132.6
Favored (26.3%) ttt180
chi angles: 178.1,167.9,169.3,147.9
0.04Å---
B 153 THR17.95--Allowed (1.6%) p
chi angles: 41.2
0.03Å---
B 165 SER14.94--Favored (20.9%) m
chi angles: 287.7
0.08Å---
B 166 LYS15.63-Favored (37.71%)
General / -158.3,162.5
OUTLIER (0%)
chi angles: 51,163.8,279.9,91.2
0.03Å---
B 167 VAL10.2-Favored (55.22%)
Ile or Val / -115.9,135.7
Favored (57.3%) t
chi angles: 170.4
0.05Å---
B 168 THR11.05-Favored (53.57%)
General / -118.3,136.6
Favored (81.2%) m
chi angles: 302.4
0.02Å---
B 169 HIS16.35-Favored (55.58%)
General / -111.3,127.2
Favored (95%) m-70
chi angles: 304.4,287.8
0.04Å---
B 170 VAL12.72-Favored (68.88%)
Ile or Val / -116.0,122.1
Favored (90.7%) t
chi angles: 174.3
0.05Å---
B 171 MET32.19-Favored (38.53%)
General / -77.6,133.1
Favored (50.9%) mmm
chi angles: 303.2,307.3,309.7
0.05Å---
B 172 ILE11.4-Favored (38.68%)
Ile or Val / -111.6,112.0
Favored (90.7%) mt
chi angles: 292.6,164.9
0.01Å---
B 173 ARG26.49-Favored (27.21%)
General / -85.1,146.4
Favored (48.8%) mtp180
chi angles: 288.8,193.3,75.2,173.8
0.04Å---
B 174 CYS30.26-Favored (14.5%)
General / -113.6,106.4
Favored (40.6%) t
chi angles: 187
0.01Å---
B 175 GLN26.25-Favored (26.9%)
General / -122.5,117.8
Favored (35.7%) mt0
chi angles: 306.7,194.3,65.9
0.08Å---
B 176 GLU40.53-Favored (4.74%)
General / 42.4,51.7
Favored (58.8%) mm-30
chi angles: 302.1,290.6,358.4
0.03Å---
B 177 LEU40.08-Allowed (0.92%)
General / 83.8,2.5
Favored (18.4%) mt
chi angles: 302.1,163.4
0.04Å---
B 178 LYS34.220.43Å
NZ with B 188 ASP OD1
Favored (30.52%)
General / -124.5,159.4
Favored (29.4%) mttm
chi angles: 297.8,185.7,177.9,317.5
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 179 TYR29.19-Favored (47.22%)
General / -117.2,142.3
Favored (71.8%) m-80
chi angles: 303.9,283.1
0.01Å---
B 180 ASP14.55-Favored (37.88%)
General / -152.6,164.3
Favored (4.2%) p0
chi angles: 66.3,85.5
0.04Å---
B 181 VAL15.39-Allowed (1.04%)
Ile or Val / -103.6,27.7
Favored (26%) m
chi angles: 299.4
0.11Å---
B 182 GLY14.78-Favored (47.73%)
Glycine / 105.4,-13.4
-----
B 183 GLY12.38-Favored (40.24%)
Glycine / -168.8,167.2
-----
B 184 GLY11.34-Favored (16.92%)
Glycine / 85.2,-138.7
-----
B 185 GLU23.31-Favored (29.81%)
General / -79.3,153.5
Favored (74.9%) mm-30
chi angles: 298.8,302.5,307.3
0.06Å---
B 186 ARG15.22-Favored (55.32%)
General / -117.5,128.8
Favored (44.1%) mtp180
chi angles: 295.1,179.6,53.5,217.4
0.03Å---
B 187 PHE18.81-Favored (23.27%)
General / -110.2,154.5
Favored (86.3%) m-80
chi angles: 299.6,86.9
0.02Å---
B 188 ASP30.370.43Å
OD1 with B 178 LYS NZ
Favored (56.54%)
General / -82.9,-13.2
Favored (70.7%) m-30
chi angles: 291,322.2
0.09Å---
B 189 SER16.59-Favored (35.89%)
General / -159.3,161.8
Favored (73.7%) p
chi angles: 71.6
0.03Å---
B 190 LEU15.33-Favored (83.94%)
General / -64.0,-36.4
Favored (52%) mt
chi angles: 287.6,176
0.04Å---
B 191 THR17.92-Favored (87.35%)
General / -58.4,-46.0
Favored (22.8%) m
chi angles: 291.2
0.06Å---
B 192 ASP23.59-Favored (93.08%)
General / -65.2,-39.7
Favored (91.8%) m-30
chi angles: 287.7,353
0.04Å- OUTLIER(S)
worst is CA-CB-CG: 4.1 σ
-
B 193 LEU11.64-Favored (75.3%)
General / -64.2,-48.6
Favored (5.4%) tt
chi angles: 179.1,155.4
0.06Å---
B 194 VAL13.83-Favored (97.32%)
Ile or Val / -61.6,-43.6
Favored (41.7%) t
chi angles: 168
0.04Å---
B 195 GLU34.68-Favored (98.85%)
General / -61.2,-42.6
Favored (63.6%) mm-30
chi angles: 283.2,300.9,315.6
0.09Å---
B 196 HIS23.48-Favored (83.01%)
General / -58.7,-47.9
Favored (69.8%) t-90
chi angles: 185.9,272.5
0.04Å---
B 197 TYR17.94-Favored (58.85%)
General / -85.1,-8.0
Favored (57.9%) m-80
chi angles: 289.8,292.6
0.13Å---
B 198 LYS29.34-Favored (68.69%)
General / -70.9,-43.3
Favored (17.4%) mtpt
chi angles: 278.2,161.6,89.3,176
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 199 LYS51.48-Favored (28.84%)
General / -82.5,-31.9
Favored (27.9%) tttm
chi angles: 190.7,192.7,180.4,286.2
0.01Å---
B 200 ASN32.18-Favored (76.97%)
Pre-Pro / -127.2,75.2
Favored (5.6%) m-40
chi angles: 310.5,267.3
0.04Å---
B 201 PRO27.53-Favored (60.53%)
Trans-Pro / -56.3,133.8
Favored (55.9%) Cg_exo
chi angles: 336.2,30.2,334.4
0.09Å---
B 202 MET27.76-Favored (44.71%)
General / -58.2,143.2
Favored (8%) mtm
chi angles: 284.3,159.8,303.4
0.03Å---
B 203 VAL20.36-Favored (67.76%)
Ile or Val / -127.3,126.5
Favored (41.8%) t
chi angles: 183.1
0.05Å---
B 204 GLU25.25-Favored (40.64%)
General / -71.7,155.3
Favored (97.5%) mt-10
chi angles: 293.1,182.3,355.6
0.02Å---
B 205 THR26.65-Favored (66.93%)
General / -65.8,-24.4
Favored (34.7%) m
chi angles: 306
0.13Å---
B 206 LEU16.36-Favored (57.25%)
General / -91.3,1.2
Favored (28.9%) mt
chi angles: 285.2,178.2
0.05Å---
B 207 GLY13.2-Favored (16.31%)
Glycine / 116.4,-12.2
-----
B 208 THR15.65-Favored (11.92%)
General / -59.9,121.5
Favored (53%) m
chi angles: 294.9
0.03Å---
B 209 VAL16-Favored (26.43%)
Ile or Val / -84.0,115.6
Favored (91.3%) t
chi angles: 175.9
0.04Å---
B 210 LEU18.72-Favored (8.85%)
General / -82.0,77.2
Favored (92.6%) mt
chi angles: 297.8,178.5
0.07Å---
B 211 GLN37.49-Favored (28.04%)
General / -75.3,125.0
Favored (37.2%) tt0
chi angles: 181.5,193.7,1.3
0.03Å---
B 212 LEU23.71-Favored (6.12%)
General / -94.5,90.2
Favored (12.1%) mt
chi angles: 314.4,183.8
0.06Å---
B 213 LYS39.36-Favored (8.46%)
General / -93.2,-44.2
Favored (11.8%) tttt
chi angles: 192.2,188.8,146.8,176.2
0.04Å---
B 214 GLN23.15-Favored (20.06%)
Pre-Pro / -153.4,148.6
Favored (2.3%) pm20
chi angles: 63.5,277.3,321.6
0.01Å---
B 215 PRO18.08-Favored (99.41%)
Trans-Pro / -60.9,143.6
Favored (30.4%) Cg_exo
chi angles: 340,29,333.2
0.10Å---
B 216 LEU14.220.49Å
HD21 with B 125 LEU HB3
Favored (54.81%)
General / -57.1,133.2
Favored (43.8%) tp
chi angles: 176.1,67.5
0.08Å---
B 217 ASN24.79-Favored (19.98%)
General / -78.2,117.9
Favored (31.4%) t0
chi angles: 184,307.3
0.03Å---
B 218 THR16.4-Favored (10.97%)
General / -118.6,-2.6
Favored (74.9%) p
chi angles: 59.9
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 219 THR13.43-Favored (16.83%)
General / -95.7,-23.7
Favored (33.3%) p
chi angles: 53.7
0.03Å---
B 220 ARG31.82-Favored (34.79%)
General / -65.1,128.2
Favored (36.9%) ttp-110
chi angles: 176.6,169.2,64.8,247.1
0.06Å---
B 221 ILE34.23-Favored (42.55%)
Ile or Val / -132.0,160.3
Favored (7.9%) pt
chi angles: 56.1,155.7
0.03Å---
B 222 ASN30.230.51Å
O with B 225 GLU HG2
Favored (39.72%)
General / -76.2,135.4
Favored (23.9%) t0
chi angles: 188.3,277.8
0.04Å---
B 223 ALA21.17-Favored (40%)
General / -50.5,-37.7
-0.05Å---
B 224 ALA32.20.76Å
HB2 with B 484 VAL HG13
Favored (66.79%)
General / -65.0,-21.2
-0.04Å---
B 225 GLU32.390.51Å
HG2 with B 222 ASN O
Favored (20.72%)
General / -104.1,19.1
Favored (10%) pt0
chi angles: 65.2,200.9,5.6
0.09Å---
B 226 ILE26.66-Favored (69.05%)
Ile or Val / -55.2,-43.1
Favored (2.9%) tp
chi angles: 180.7,54.1
0.06Å---
B 227 GLU36.990.41Å
HA with B 519 GLN HE21
Favored (83.42%)
General / -63.9,-46.8
Favored (26.9%) tt0
chi angles: 178.3,188.3,298
0.09Å---
B 228 SER29.43-Favored (86.13%)
General / -58.0,-42.9
Favored (2.3%) t
chi angles: 158.6
0.07Å---
B 229 ARG19.04-Favored (74.39%)
General / -70.5,-38.9
Favored (17.7%) tpp80
chi angles: 177.4,50.3,56.8,96.1
0.04Å---
B 230 VAL16.87-Favored (85.82%)
Ile or Val / -62.6,-39.8
Favored (38.6%) t
chi angles: 167.2
0.08Å---
B 231 ARG39.09-Favored (81.41%)
General / -63.3,-47.6
Favored (13.9%) ttm110
chi angles: 204.1,186,313.2,113
0.08Å---
B 232 GLU51.65-Favored (96.03%)
General / -60.2,-43.2
Favored (15%) tt0
chi angles: 166.1,179.4,300.4
0.01Å---
B 233 LEU18.39-Favored (61%)
General / -73.0,-20.5
Favored (34.5%) mt
chi angles: 284.3,175.1
0.04Å---
B 234 SER27.45-Favored (49.41%)
General / -85.6,-13.2
Favored (20.7%) m
chi angles: 287.7
0.03Å---
B 235 LYS45.66--Favored (36.9%) mttp
chi angles: 288.5,176,164.6,75.3
0.05Å---
B 245 GLN47.430.57Å
OE1 with B 512 ARG NH1
-Favored (66.4%) mt0
chi angles: 297.3,168.2,299.2
0.03Å---
B 246 GLY25.26-Favored (65.97%)
Glycine / -57.2,-33.9
-----
B 247 PHE19.29-Favored (91.36%)
General / -61.1,-39.8
Favored (21.3%) m-80
chi angles: 276.6,291.5
0.15Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 248 TRP32.22-Favored (85.09%)
General / -64.2,-46.2
Favored (34.8%) t60
chi angles: 196.4,91.1
0.01Å---
B 249 GLU44.480.57Å
OE2 with B 601 5OD H13
Favored (91.98%)
General / -61.1,-46.1
Favored (36.8%) tt0
chi angles: 184.4,164.6,332.3
0.09Å---
B 250 GLU15.05-Favored (82.64%)
General / -67.5,-42.5
Favored (30%) tt0
chi angles: 188.3,178.2,286.4
0.05Å---
B 251 PHE13.25-Favored (88.39%)
General / -64.7,-45.1
Favored (65%) t80
chi angles: 180.3,66.4
0.04Å---
B 252 GLU24.12-Favored (66.65%)
General / -67.5,-27.1
Favored (44.1%) mm-30
chi angles: 285.7,304.3,333.9
0.13Å---
B 253 THR11.79-Favored (81.64%)
General / -68.1,-37.7
Favored (94.7%) m
chi angles: 300.9
0.07Å---
B 254 LEU12.08-Favored (88.97%)
General / -64.6,-44.9
Favored (63.3%) tp
chi angles: 175.3,61.1
0.04Å---
B 255 GLN16.72-Favored (75.8%)
General / -61.2,-34.9
Favored (12.6%) mm110
chi angles: 298.5,298.9,78.2
0.06Å---
B 256 GLN33.99-Favored (65.94%)
General / -59.8,-26.6
Favored (40.3%) tt0
chi angles: 177.8,166.4,309
0.04Å---
B 257 GLN17.99-Favored (57.99%)
General / -87.5,-1.5
Favored (96.7%) mm-40
chi angles: 293.3,297.1,304.7
0.06Å---
B 258 GLU18.03-Favored (63.4%)
General / -69.7,-16.9
Favored (8.6%) pt0
chi angles: 81.6,190.7,1.1
0.05Å---
B 259 ACYS28.12-Favored (60.88%)
General / -72.7,-12.1
Favored (14.3%) p
chi angles: 55.3
0.03Å---
B 259 BCYS28.12-Favored (62.13%)
General / -71.1,-14.0
Allowed (0.5%) m
chi angles: 264.4
0.06Å---
B 260 LYS33.73-Favored (44.31%)
General / -76.7,-4.6
Favored (6.9%) mttp
chi angles: 293.6,200.9,160.3,38.8
0.07Å---
B 261 LEU15.85-Favored (10.86%)
General / -116.8,25.0
Favored (65.4%) mt
chi angles: 303,182.8
0.07Å---
B 262 LEU15.42-Favored (7.06%)
General / -87.6,62.4
Favored (88.5%) mt
chi angles: 293.4,169.2
0.08Å---
B 263 TYR23.73-Favored (28.36%)
General / -78.4,159.3
Favored (36.9%) m-80
chi angles: 301.3,305
0.02Å---
B 264 SER19.58-Favored (56.05%)
General / -64.1,145.4
Favored (96%) p
chi angles: 65
0.09Å---
B 265 ARG36.68-Favored (2.47%)
General / -136.6,43.1
Favored (20.3%) mtm110
chi angles: 300,164,295.7,129.2
0.05Å---
B 266 LYS39.56-Favored (96.06%)
General / -62.6,-40.2
Favored (2.9%) mptt
chi angles: 274.8,40.8,163.4,178
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 267 GLU26.32-Favored (94.03%)
General / -64.2,-39.5
Favored (77.1%) mm-30
chi angles: 290.9,292.4,325
0.09Å---
B 268 GLY11.94-Favored (66.06%)
Glycine / -67.5,-15.4
-----
B 269 GLN31.95-Favored (31.63%)
General / -94.0,-11.1
Favored (90.8%) mt0
chi angles: 289,167.7,331.7
0.04Å---
B 270 ARG33.78-Favored (54.68%)
General / -59.4,141.4
Favored (74.1%) mtp180
chi angles: 297.4,172.9,58.6,178
0.08Å---
B 271 GLN26.130.63Å
HA with B 274 LYS HE3
Favored (7.15%)
General / -43.6,-51.1
Favored (69.7%) tp40
chi angles: 176.5,58.2,47.4
0.04Å---
B 272 GLU30.31-Favored (62.02%)
General / -68.5,-13.0
Favored (37.8%) mp0
chi angles: 297.8,93,1.4
0.11Å---
B 273 ASN11.18-Favored (15.78%)
General / -108.1,-8.6
Favored (95.5%) m-40
chi angles: 291.2,332.3
0.02Å---
B 274 LYS29.530.63Å
HE3 with B 271 GLN HA
Favored (89.13%)
General / -58.5,-45.2
Favored (6.5%) mttt
chi angles: 287.4,186.4,224.2,159.2
0.05Å---
B 275 ASN35.02-Favored (13.44%)
General / -80.5,6.0
Favored (16.8%) p0
chi angles: 77.8,348.4
0.12Å---
B 276 LYS14.57-Favored (54.66%)
General / -95.4,3.2
Favored (67.1%) mttt
chi angles: 298.3,164.3,193.3,174.7
0.02Å---
B 277 ASN11.35-Favored (53.81%)
General / -109.2,132.8
Favored (80.1%) m-40
chi angles: 300.8,310.9
0.12Å---
B 278 ARG22.01-Favored (89.24%)
General / -66.4,-40.0
Favored (37.3%) ttm-80
chi angles: 187.9,169.9,274.1,278.3
0.08Å---
B 279 TYR23.75-Favored (43.31%)
General / -122.3,124.2
Favored (55.6%) m-80
chi angles: 306.8,279.3
0.11Å---
B 280 LYS38.01-Favored (34.75%)
General / -50.4,-36.8
Favored (4.6%) ttpp
chi angles: 162.7,161.1,86.3,72.5
0.03Å---
B 281 ASN31.29-Favored (23.23%)
General / -108.9,4.3
Favored (75.3%) m-40
chi angles: 299,302
0.02Å---
B 282 ILE13.97-Favored (10.38%)
Ile or Val / -101.4,100.4
Favored (76.6%) mt
chi angles: 299.6,174.4
0.12Å---
B 283 LEU16.75-Favored (54.46%)
Pre-Pro / -126.5,161.1
Favored (85.4%) mt
chi angles: 299,173.6
0.11Å---
B 284 PRO11.58-Favored (5.54%)
Trans-Pro / -87.0,139.8
Favored (77.9%) Cg_endo
chi angles: 30.1,328,21.5
0.04Å---
B 285 PHE13.15-Favored (56.46%)
General / -60.1,141.1
Favored (30.3%) m-80
chi angles: 298.9,309.3
0.07Å---
B 286 ASP14.94-Favored (81.6%)
General / -58.1,-40.5
Favored (78.2%) m-30
chi angles: 294.5,326.6
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 287 HIS18.28-Favored (60.03%)
General / -76.5,-14.6
Favored (28.9%) p-80
chi angles: 78.4,285.7
0.13Å---
B 288 THR15.77-Favored (7.93%)
General / -125.1,3.4
Favored (28.1%) p
chi angles: 52.6
0.06Å---
B 289 ARG13.61-Favored (47.92%)
General / -65.7,150.8
Favored (31.8%) ptt90
chi angles: 73.3,183.1,184.9,100.6
0.03Å---
B 290 VAL17.030.42Å
HG11 with B 344 MET HG3
Favored (22.14%)
Ile or Val / -74.9,119.2
Favored (96.7%) t
chi angles: 175.1
0.02Å---
B 291 VAL13.84-Favored (48.98%)
Ile or Val / -97.1,122.8
Favored (70.2%) t
chi angles: 178.7
0.04Å---
B 292 LEU15.13-Favored (32.51%)
General / -91.1,121.0
Favored (82.1%) mt
chi angles: 299.4,180
0.04Å---
B 293 HIS32.62--Favored (15.5%) m-70
chi angles: 321.4,290.1
0.04Å---
B 301 VAL32.41--Favored (71.3%) t
chi angles: 172.3
0.02Å---
B 302 SER23.23-Favored (12.39%)
General / -118.4,9.4
Favored (56%) p
chi angles: 57.3
0.06Å---
B 303 ASP19.92-Favored (38.69%)
General / -102.9,9.6
Favored (9.8%) p0
chi angles: 79.2,350.8
0.03Å---
B 304 TYR10.76-Favored (56.07%)
General / -114.5,133.1
Favored (84.3%) t80
chi angles: 181,83.3
0.04Å---
B 305 ILE12.09-Favored (19.27%)
Ile or Val / -143.0,148.6
Favored (21.4%) tt
chi angles: 186,166
0.15Å---
B 306 ASN13.02-Favored (6.55%)
General / -82.3,87.7
Favored (39.6%) t0
chi angles: 193.5,322.2
0.06Å---
B 307 ALA11.31-Favored (10.69%)
General / -163.1,146.3
-0.14Å---
B 308 ASN11.85-Favored (51.47%)
General / -131.6,145.0
Favored (18.7%) m110
chi angles: 297.7,89.8
0.08Å---
B 309 ILE21.690.41Å
HD13 with B 328 ILE HG12
Favored (35.42%)
Ile or Val / -72.6,130.9
Favored (7.9%) mm
chi angles: 300.4,283.8
0.06Å---
B 310 ILE13.37-Favored (28.37%)
Ile or Val / -113.8,109.4
Favored (6.3%) mm
chi angles: 316.2,292.5
0.06Å---
B 311 MET38.59-Favored (53.2%)
Pre-Pro / -109.3,117.4
Favored (62.8%) tpp
chi angles: 180.2,60.6,70.1
0.09Å---
B 312 PRO21.72--Favored (15.7%) Cg_exo
chi angles: 343.7,38.4,315.2
0.08Å---
B 325 LYS20.69--Allowed (2%) ttmt
chi angles: 193.2,187.8,276.2,142.8
0.18Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 326 SER17.7-Favored (5.94%)
General / -116.6,174.7
Favored (76.1%) p
chi angles: 60
0.05Å---
B 327 TYR13.94-Favored (39.91%)
General / -133.7,159.6
Favored (8.7%) m-80
chi angles: 312.6,81.4
0.08Å---
B 328 ILE14.820.41Å
HG12 with B 309 ILE HD13
Favored (63.93%)
Ile or Val / -115.9,120.1
Favored (70.2%) mt
chi angles: 293.8,161.1
0.09Å---
B 329 ALA12.04-Favored (41.05%)
General / -98.2,122.2
-0.06Å---
B 330 THR14.25-Favored (17.98%)
General / -140.0,169.3
Favored (8.8%) t
chi angles: 191.6
0.20Å---
B 331 GLN14.41-Favored (18.6%)
General / -83.8,165.7
Favored (20.1%) pt0
chi angles: 69.7,178.1,16
0.07Å---
B 332 GLY14.75-Favored (30.45%)
Glycine / -67.5,133.8
-----
B 333 CYS21.84-Favored (14.15%)
General / -53.7,146.2
Favored (72.8%) m
chi angles: 287.7
0.18Å---
B 334 LEU16.93-Favored (11.85%)
General / -100.9,164.4
Favored (24.3%) mt
chi angles: 297.8,162.5
0.09Å---
B 335 GLN45.62-Favored (68.65%)
General / -54.4,-40.7
Favored (12.6%) pt0
chi angles: 55.7,191.7,47.1
0.28Å---
B 336 ASN15.96-Favored (48.22%)
General / -86.2,2.1
Favored (15%) p0
chi angles: 56.4,311.6
0.08Å---
B 337 THR11.58-Favored (12.3%)
General / -117.7,5.2
Favored (18.8%) p
chi angles: 73.1
0.06Å---
B 338 VAL12.9-Favored (91.44%)
Ile or Val / -63.5,-47.5
Favored (37.2%) t
chi angles: 166.8
0.03Å---
B 339 ASN12.46-Favored (84.79%)
General / -57.9,-42.5
Favored (56.4%) m-40
chi angles: 293.6,357.2
0.07Å---
B 340 ASP28.82-Favored (88.11%)
General / -66.0,-38.2
Favored (80%) m-30
chi angles: 295.5,332.5
0.09Å---
B 341 PHE12.2-Favored (66.76%)
General / -54.1,-50.5
Favored (75.7%) t80
chi angles: 177.1,87.1
0.03Å---
B 342 TRP11.21-Favored (74.75%)
General / -67.2,-33.1
Favored (77.2%) m100
chi angles: 285.8,113.8
0.09Å---
B 343 ARG18.06-Favored (83.78%)
General / -59.1,-40.0
Favored (61.8%) mtp180
chi angles: 284,171.1,67.5,206.1
0.03Å---
B 344 MET15.20.42Å
HG3 with B 290 VAL HG11
Favored (68.26%)
General / -65.7,-49.5
Favored (52.4%) ttp
chi angles: 175.7,180.8,64.4
0.01Å---
B 345 VAL11.58-Favored (87.64%)
Ile or Val / -57.9,-46.2
Favored (49.7%) t
chi angles: 169.3
0.08Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 346 PHE15.23-Favored (61.3%)
General / -63.3,-52.6
Favored (69.8%) t80
chi angles: 185.6,84.9
0.07Å---
B 347 GLN16.52-Favored (86.36%)
General / -59.2,-40.6
Favored (33.4%) tt0
chi angles: 173.3,180.8,286.1
0.03Å---
B 348 GLU22.59-Favored (58.58%)
General / -87.4,-2.4
Favored (83.3%) mm-30
chi angles: 296.5,298.2,320.9
0.07Å---
B 349 ASN25.2-Favored (11.26%)
General / 65.8,26.8
Favored (52.3%) t0
chi angles: 200.2,29.1
0.10Å---
B 350 SER12.5-Favored (55.47%)
General / -68.0,137.8
Favored (55.9%) m
chi angles: 299.9
0.04Å---
B 351 ARG17.86-Favored (10.31%)
General / -119.5,-5.4
Favored (28.7%) mmt90
chi angles: 304,306.2,182.3,82.5
0.01Å---
B 352 VAL13.07-Favored (33.5%)
Ile or Val / -139.0,129.7
Favored (72.9%) t
chi angles: 178.5
0.05Å---
B 353 ILE12.82-Favored (57.79%)
Ile or Val / -118.6,135.8
Favored (72.3%) mt
chi angles: 301.4,168.1
0.09Å---
B 354 VAL14.32-Favored (45.49%)
Ile or Val / -115.3,114.1
Favored (78%) t
chi angles: 172.9
0.05Å---
B 355 MET15.270.47Å
HG3 with B 458 HIS CE1
Favored (47.93%)
General / -107.4,123.1
Favored (26.9%) ttt
chi angles: 175.1,169.7,178.3
0.07Å---
B 356 THR22.26-Favored (7.59%)
General / -116.4,30.0
Favored (69.9%) p
chi angles: 62.4
0.05Å---
B 357 THR21.25-Favored (43.36%)
General / -141.7,151.9
Favored (6.7%) t
chi angles: 182.3
0.09Å---
B 358 LYS21.71-Favored (28.42%)
General / -70.0,162.3
Favored (45.1%) mttp
chi angles: 295.9,181.1,183.2,77.1
0.01Å---
B 359 GLU25.38-Favored (83.86%)
General / -60.4,-38.4
Favored (40.9%) mt-10
chi angles: 288.8,175.4,54.9
0.09Å---
B 360 VAL21.33-Favored (64.98%)
Ile or Val / -130.7,131.1
Favored (99.4%) t
chi angles: 175.4
0.07Å---
B 361 GLU27.06-Favored (41.73%)
General / -135.0,135.8
Favored (94.5%) mt-10
chi angles: 294.4,184.1,358.4
0.04Å---
B 362 ARG41.23-Favored (24.46%)
General / 52.0,38.6
Favored (55.3%) mtp85
chi angles: 286.2,164.1,73.4,93.1
0.01Å---
B 363 GLY30.94-Favored (78.68%)
Glycine / 73.5,9.9
-----
B 364 LYS54.59-Favored (52.99%)
General / -118.8,138.0
Favored (7.7%) mttm
chi angles: 292.5,202.9,188.5,263.4
0.03Å---
B 365 SER28.98-Favored (26.47%)
General / -71.5,125.2
Favored (18.4%) t
chi angles: 186.4
0.08Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 366 LYS30.69-Favored (13.46%)
General / -107.9,-19.6
Favored (72.1%) mmtt
chi angles: 301.6,294.7,179.2,182
0.08Å---
B 367 CYS17.93-Favored (2.21%)
General / -165.6,129.1
Favored (55.2%) t
chi angles: 183.7
0.04Å---
B 368 VAL28.81-Favored (5.97%)
Ile or Val / -76.0,155.1
Favored (61.2%) t
chi angles: 171
0.08Å---
B 369 LYS25.42-Favored (9.58%)
General / -75.9,109.5
Favored (38.8%) tttm
chi angles: 179.8,168.6,177.7,283.3
0.05Å---
B 370 TYR13.42-Favored (32.44%)
General / -105.8,10.7
Favored (35.2%) p90
chi angles: 57.6,80.9
0.04Å---
B 371 TRP13.8-Favored (69.56%)
Pre-Pro / -124.5,154.2
Favored (54.7%) p90
chi angles: 60.7,91.9
0.05Å---
B 372 PRO13.51-Favored (41.54%)
Trans-Pro / -74.5,160.5
Favored (11.9%) Cg_exo
chi angles: 346.1,26.6,331.2
0.15Å---
B 373 ASP26.46-Favored (8.95%)
General / -57.1,155.1
Favored (82.9%) m-30
chi angles: 295.5,342
0.04Å---
B 374 GLU18.48-Favored (30.5%)
General / -51.7,131.8
Favored (29.5%) tt0
chi angles: 194.7,178.3,31.9
0.03Å---
B 375 TYR18.39-Favored (3.03%)
General / 74.4,-1.6
Favored (24.9%) m-80
chi angles: 308.4,305.6
0.08Å---
B 376 ALA11.94-Favored (13.99%)
General / -91.8,163.6
-0.06Å---
B 377 LEU17.64-Favored (53.66%)
General / -123.7,134.7
Favored (16.7%) tp
chi angles: 185,73.7
0.17Å---
B 378 LYS38.68-Favored (51.17%)
General / -133.9,147.7
Favored (3.6%) mtpp
chi angles: 284.4,202.5,76.3,90.1
0.05Å---
B 379 GLU12.68-Favored (45.5%)
General / -99.3,131.1
Favored (94.4%) mt-10
chi angles: 289.8,181.3,3
0.07Å---
B 380 TYR13.86-Favored (3.95%)
General / -116.7,92.7
Favored (76.3%) m-80
chi angles: 303.5,280.8
0.03Å---
B 381 GLY11.96-Favored (31.18%)
Glycine / 55.7,-123.7
-----
B 382 VAL21.35-Favored (9.99%)
Ile or Val / -82.9,-6.3
Favored (12.5%) m
chi angles: 305.5
0.03Å---
B 383 MET19.29-Favored (40.63%)
General / -103.8,138.3
Favored (24.1%) mmt
chi angles: 296.9,302.8,162.8
0.07Å---
B 384 ARG15.34-Favored (55.48%)
General / -113.0,132.2
Favored (27.9%) ttm170
chi angles: 178.6,176.6,283.2,145.6
0.11Å---
B 385 VAL11.31-Favored (63.11%)
Ile or Val / -131.1,129.2
Favored (86.4%) t
chi angles: 177.4
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 386 ARG22.09-Favored (49.91%)
General / -106.3,134.2
Favored (71.3%) ttm-80
chi angles: 182.8,171.5,301.9,273.6
0.17Å---
B 387 ASN12.67-Favored (15.59%)
General / -92.7,103.2
Favored (52.2%) t0
chi angles: 181.4,343.5
0.11Å---
B 388 VAL21.33-Favored (51.52%)
Ile or Val / -74.1,-43.3
Favored (90.3%) t
chi angles: 174.2
0.04Å---
B 389 LYS23.57-Favored (2.85%)
General / -168.7,141.6
Favored (12%) tptp
chi angles: 190,73.7,193,69.5
0.09Å---
B 390 GLU24.53-Favored (40.41%)
General / -111.2,144.4
Favored (57%) mt-10
chi angles: 299.5,195.6,357.5
0.05Å---
B 391 SER18.86-Favored (24.94%)
General / -131.3,121.5
Favored (65.3%) m
chi angles: 297.3
0.06Å---
B 392 ALA20.34-Favored (44.52%)
General / -106.8,137.6
-0.03Å---
B 393 ALA15.15-Favored (4.24%)
General / -122.6,-179.5
-0.07Å---
B 394 HIS15.46-Favored (82.69%)
General / -64.8,-46.2
Favored (86.3%) t70
chi angles: 172.9,73.9
0.05Å---
B 395 ASP23.51-Favored (28.93%)
General / -87.6,-18.8
Favored (34.7%) m-30
chi angles: 285.8,312.4
0.04Å---
B 396 TYR16.41-Favored (31.25%)
General / -158.8,157.2
Favored (48.4%) p90
chi angles: 70.2,272.4
0.06Å---
B 397 THR12.7-Favored (51.45%)
General / -112.4,136.8
Favored (86%) m
chi angles: 301.5
0.07Å---
B 398 LEU14.69-Favored (51.32%)
General / -103.8,129.9
Favored (42.6%) tp
chi angles: 172.4,59.3
0.04Å---
B 399 ARG13.21-Favored (43.79%)
General / -117.0,122.3
Favored (48%) mtt90
chi angles: 310.9,190.5,174,94.7
0.09Å---
B 400 GLU16.88-Favored (20.2%)
General / -87.7,110.1
Favored (81.8%) tt0
chi angles: 177.3,179.5,349.8
0.05Å---
B 401 LEU19.83-Favored (38.08%)
General / -110.9,145.6
Favored (42.5%) mt
chi angles: 307.9,178
0.06Å---
B 402 LYS43.83-Favored (51.84%)
General / -113.9,124.3
Favored (73.3%) mttt
chi angles: 276.5,181.5,184.1,180.9
0.08Å---
B 403 LEU10.89-Favored (52.48%)
General / -112.8,136.4
Favored (18.2%) tp
chi angles: 166.8,65.7
0.05Å---
B 404 SER14.31-Favored (34.13%)
General / -153.8,166.1
Favored (94.3%) p
chi angles: 63.3
0.03Å---
B 405 LYS35.29-Favored (34.1%)
General / -92.7,135.4
Favored (4.3%) tttp
chi angles: 183.5,148.6,147.6,71
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 406 VAL18.75-Favored (22.31%)
Ile or Val / -60.6,137.9
Favored (61.6%) t
chi angles: 171
0.08Å---
B 407 GLY21.98-Favored (86.27%)
Glycine / 85.4,-4.0
-----
B 408 GLN39.25-Favored (2.11%)
General / -136.1,84.8
Favored (14.5%) mt0
chi angles: 311.2,200.5,3.1
0.05Å---
B 409 GLY34.1-Favored (76.68%)
Glycine / -55.0,-41.2
-----
B 410 ASN37.74-Allowed (0.21%)
General / -63.8,5.6
Favored (21%) p0
chi angles: 59.4,321.2
0.13Å---
B 411 THR15.57-Favored (25.28%)
General / -105.2,-1.5
Favored (71.8%) p
chi angles: 62
0.04Å---
B 412 GLU39.28-Favored (57.69%)
General / -65.0,137.4
Favored (6.7%) tt0
chi angles: 194,195.9,290.5
0.03Å---
B 413 ARG18.1-Favored (36.22%)
General / -143.9,149.0
Allowed (1.1%) pmm-80
chi angles: 74.4,296.4,310.8,282.2
0.09Å---
B 414 THR15.21-Favored (37.63%)
General / -78.2,135.4
Favored (52.7%) m
chi angles: 304
0.05Å---
B 415 VAL14.46-Favored (72.96%)
Ile or Val / -118.5,124.3
Favored (81.2%) t
chi angles: 176.6
0.05Å---
B 416 TRP12.97-Favored (30%)
General / -100.2,115.5
Favored (60.7%) m100
chi angles: 304,87.5
0.07Å---
B 417 GLN13.81-Favored (26.36%)
General / -100.3,113.6
Favored (7.3%) tt0
chi angles: 186.4,210.4,33.4
0.02Å---
B 418 TYR12.480.45Å
HB3 with B 438 PHE CE1
Favored (22.79%)
General / -97.6,110.2
Favored (74.3%) m-80
chi angles: 287.3,88.2
0.03Å---
B 419 HIS15.3-Favored (8.94%)
General / -107.8,99.5
Favored (18.6%) t-170
chi angles: 185,180.7
0.09Å---
B 420 PHE13.02-Favored (33.4%)
General / -73.4,127.7
Favored (19%) t80
chi angles: 198.9,79.1
0.03Å---
B 421 ARG34.16-Favored (10.46%)
General / -119.1,-5.8
Favored (28.4%) mtm110
chi angles: 284.4,183.2,292.9,89
0.03Å---
B 422 THR16.39-Favored (23.64%)
General / -110.3,9.3
Favored (48.6%) p
chi angles: 55.9
0.04Å---
B 423 TRP20.83-Favored (95.16%)
Pre-Pro / -62.2,135.6
Favored (26.3%) t-100
chi angles: 191,277.4
0.04Å---
B 424 PRO20.5-Favored (53.43%)
Trans-Pro / -70.4,159.3
Favored (54%) Cg_endo
chi angles: 32.6,317.7,35.2
0.07Å---
B 425 ASP33.04-Favored (99.08%)
General / -63.2,-41.5
Favored (77%) m-30
chi angles: 285.7,335.6
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 426 HIS46.29-Favored (44.55%)
General / -126.7,154.1
Allowed (0.9%) m-70
chi angles: 280.5,4.1
0.20Å---
B 427 GLY31.54-Favored (43.84%)
Glycine / 76.3,-154.1
-----
B 428 VAL13.64-Favored (44.56%)
Pre-Pro / -132.2,164.2
Favored (30.6%) m
chi angles: 300.3
0.02Å---
B 429 PRO14.73-Favored (97.73%)
Trans-Pro / -60.8,142.4
Favored (65.1%) Cg_exo
chi angles: 335.6,35.8,325.9
0.06Å---
B 430 SER20.11-Favored (63.88%)
General / -70.4,-26.9
Favored (90.4%) p
chi angles: 68.6
0.06Å---
B 431 ASP35.58-Favored (24.24%)
Pre-Pro / -132.2,133.8
Favored (6.3%) t0
chi angles: 165.9,5.7
0.06Å- OUTLIER(S)
worst is CA-CB-CG: 8.2 σ
-
B 432 PRO16.130.52Å
HG3 with B 516 MET HG2
Favored (6.24%)
Trans-Pro / -87.7,-8.0
Favored (69.6%) Cg_endo
chi angles: 29.5,327.1,23.6
0.04Å---
B 433 GLY14.83-Favored (24.45%)
Glycine / -47.7,-46.9
-----
B 434 GLY13.19-Favored (47.92%)
Glycine / -60.8,-53.1
-----
B 435 VAL13-Favored (75%)
Ile or Val / -54.9,-45.3
Favored (31.4%) t
chi angles: 165.4
0.07Å---
B 436 LEU12.17-Favored (83.94%)
General / -67.7,-38.6
Favored (42%) mt
chi angles: 285.2,174.8
0.04Å---
B 437 ASP25.44-Favored (81.71%)
General / -68.0,-37.5
Favored (74.3%) m-30
chi angles: 292.4,354.9
0.11Å---
B 438 PHE12.670.45Å
CE1 with B 418 TYR HB3
Favored (53.3%)
General / -62.0,-53.6
Favored (77%) t80
chi angles: 172.8,82.9
0.10Å---
B 439 LEU15.91-Favored (76.91%)
General / -62.0,-34.8
Favored (18.6%) mt
chi angles: 283.7,180
0.04Å---
B 440 GLU23.14-Favored (91.14%)
General / -60.3,-46.1
Favored (17.7%) tp30
chi angles: 199.8,73.1,9.6
0.05Å---
B 441 GLU22.820.43Å
OE1 with B 705 HOH O
Favored (83.43%)
General / -66.3,-44.4
Favored (69.5%) tp30
chi angles: 177.4,68.2,17.2
0.03Å---
B 442 VAL16.92-Favored (83%)
Ile or Val / -58.1,-42.4
Favored (53.8%) t
chi angles: 169.9
0.01Å---
B 443 HIS15.64-Favored (73.37%)
General / -58.1,-50.5
Favored (91.7%) t70
chi angles: 177.5,74.3
0.02Å---
B 444 HIS23.47-Favored (91.19%)
General / -64.4,-38.5
Favored (70.2%) m90
chi angles: 286.3,79.5
0.15Å---
B 445 LYS11.06-Favored (50.64%)
General / -57.2,-54.1
Favored (19.1%) tppt
chi angles: 182.8,63.7,70.3,175.1
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 446 GLN12.74-Favored (77.98%)
General / -56.9,-48.5
Favored (25.8%) tp40
chi angles: 174.5,73.1,3.4
0.07Å---
B 447 GLU21.87-Favored (70.86%)
General / -61.5,-30.9
Favored (91.9%) tt0
chi angles: 184.4,180.2,1.1
0.05Å---
B 448 SER12.11-Favored (59.38%)
General / -75.0,-10.3
Favored (24.6%) p
chi angles: 78.6
0.04Å---
B 449 ILE14.07-Favored (37.67%)
Ile or Val / -109.4,111.8
Favored (62.6%) mt
chi angles: 303,167
0.06Å---
B 450 MET51.61-Favored (39.21%)
General / -59.5,128.9
Favored (55.9%) mmm
chi angles: 277.8,297.2,291.9
0.05Å---
B 451 ASP49.29-Favored (14.32%)
General / 61.3,24.2
Favored (62.9%) m-30
chi angles: 294,309.7
0.07Å---
B 452 ALA14.13-Favored (44.99%)
General / -56.3,140.4
-0.03Å---
B 453 GLY13.16-Favored (31.31%)
Glycine / -79.4,-166.0
-----
B 454 PRO14.68-Favored (78.94%)
Trans-Pro / -58.8,149.2
Favored (2.2%) Cg_exo
chi angles: 355.6,7.9,351.4
0.15Å- OUTLIER(S)
worst is N-CA-CB: 4.5 σ
-
B 455 VAL11.92-Favored (39.54%)
Ile or Val / -80.6,126.3
Favored (63.3%) t
chi angles: 171.3
0.06Å---
B 456 VAL13.44-Favored (34.55%)
Ile or Val / -85.2,131.3
Favored (49.3%) t
chi angles: 169.3
0.05Å---
B 457 VAL13.36-Favored (60.47%)
Ile or Val / -131.8,128.7
Favored (33.9%) t
chi angles: 184.9
0.06Å---
B 458 HIS13.930.47Å
CE1 with B 355 MET HG3
Favored (42.33%)
General / -145.6,154.6
Favored (26.6%) p90
chi angles: 72.9,81.5
0.09Å---
B 459 CYS20.32-Allowed (0.24%)
General / -126.6,-122.9
Favored (5.9%) p
chi angles: 50.8
0.15Å---
B 460 SER18.46-Allowed (0.42%)
General / -91.9,-77.8
Favored (62.8%) p
chi angles: 58.1
0.07Å---
B 461 ALA12.94-Favored (41.83%)
General / -81.5,-19.6
-0.04Å---
B 462 GLY9.89-Favored (45.25%)
Glycine / 78.5,31.6
-----
B 463 ILE15.7-Allowed (0.49%)
Ile or Val / -133.5,-38.9
Favored (36.9%) pt
chi angles: 62.2,177.2
0.09Å---
B 464 GLY10.76-Allowed (1.11%)
Glycine / -80.0,-74.2
-- OUTLIER(S)
worst is N--CA: 4.6 σ
--
B 465 ARG15.31-Favored (97.16%)
General / -64.1,-41.7
Favored (66.3%) mtt180
chi angles: 292.2,181,200.8,177.8
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 466 THR12.96-Favored (82.78%)
General / -58.6,-47.9
Favored (13.8%) m
chi angles: 289
0.04Å---
B 467 GLY10.41-Favored (95.38%)
Glycine / -62.6,-37.8
-----
B 468 THR11.22-Favored (65.66%)
General / -66.7,-49.6
Favored (78%) m
chi angles: 296.3
0.06Å---
B 469 PHE16.6-Favored (96.21%)
General / -61.0,-45.1
Favored (20.4%) m-80
chi angles: 275.5,73.1
0.02Å---
B 470 ILE12.09-Favored (98.23%)
Ile or Val / -62.0,-45.7
Favored (64.2%) mt
chi angles: 287.4,168.8
0.12Å---
B 471 VAL11.44-Favored (88.37%)
Ile or Val / -65.5,-40.5
Favored (25.7%) t
chi angles: 165
0.10Å---
B 472 ILE9.75-Favored (95.22%)
Ile or Val / -60.9,-43.1
Favored (98.7%) mt
chi angles: 292.3,167.6
0.09Å---
B 473 ASP15.32-Favored (95.59%)
General / -62.3,-44.8
Favored (20.7%) t70
chi angles: 195.5,58.2
0.04Å---
B 474 ILE12.22-Favored (95.06%)
Ile or Val / -60.0,-45.7
Favored (89.5%) mt
chi angles: 294.9,165.9
0.07Å---
B 475 LEU11.92-Favored (65.78%)
General / -72.9,-40.1
Favored (73.9%) mt
chi angles: 294.7,167.2
0.04Å---
B 476 ILE22.39-Favored (48.62%)
Ile or Val / -68.7,-30.9
Favored (33.9%) pt
chi angles: 61.3,165.5
0.20Å---
B 477 ASP34.7-Favored (87.64%)
General / -58.0,-44.9
OUTLIER (0.1%)
chi angles: 232.7,310.4
0.13Å---
B 478 ILE18.83-Favored (83.97%)
Ile or Val / -57.4,-47.8
Favored (81.9%) mt
chi angles: 295.4,164.4
0.12Å---
B 479 ILE20.36-Favored (61.59%)
Ile or Val / -71.1,-36.1
Favored (9.5%) mt
chi angles: 296,149
0.07Å---
B 480 ARG22.64-Favored (88.93%)
General / -66.6,-41.0
Favored (40.2%) ttm110
chi angles: 188.7,185.1,297.4,99.6
0.04Å---
B 481 GLU49.41-Favored (14.08%)
General / -79.1,-48.6
Favored (31.5%) mm-30
chi angles: 288.1,285.9,300.9
0.04Å---
B 482 LYS55.66-Favored (27.76%)
General / -93.1,-14.0
Favored (36.2%) mttp
chi angles: 283.2,172.1,181.1,55.5
0.04Å---
B 483 GLY27.36-Favored (53.74%)
Glycine / 78.0,-176.9
-----
B 484 VAL31.550.76Å
HG13 with B 224 ALA HB2
Favored (24.23%)
Ile or Val / -68.0,-19.0
OUTLIER (0%)
chi angles: 132.6
0.10Å---
B 485 ASP39.37-Favored (3.93%)
General / -93.4,66.3
Favored (74.5%) m-30
chi angles: 289.3,328.1
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 486 CYS26.23-Favored (46.14%)
General / -135.7,157.7
Favored (26.6%) p
chi angles: 64.4
0.03Å---
B 487 ASP34.08-Favored (35.81%)
General / -94.5,135.5
Favored (56.1%) m-30
chi angles: 276.9,353
0.10Å---
B 488 ILE26-Favored (52.3%)
Ile or Val / -131.1,138.9
Favored (41.8%) pt
chi angles: 59.4,173.3
0.08Å---
B 489 ASP13.4-Favored (4.67%)
General / -132.1,99.3
Favored (56.7%) t0
chi angles: 189.5,339.9
0.04Å---
B 490 VAL13.7-Favored (51.11%)
Pre-Pro / -61.5,-54.6
Favored (65.5%) t
chi angles: 171.6
0.13Å---
B 491 PRO11.11-Favored (64.39%)
Trans-Pro / -64.2,-31.5
Favored (27.9%) Cg_endo
chi angles: 20.9,329.1,29.7
0.09Å---
B 492 LYS33.71-Favored (86.48%)
General / -63.7,-46.2
Favored (34%) tttp
chi angles: 181.8,164,162.3,64.4
0.09Å---
B 493 THR11.4-Favored (95.49%)
General / -60.1,-43.7
Favored (50.8%) m
chi angles: 304.2
0.13Å- OUTLIER(S)
worst is OG1-CB-CG2: 4.7 σ
-
B 494 ILE14.41-Favored (95.32%)
Ile or Val / -65.2,-44.1
Favored (92.6%) mt
chi angles: 296.2,172
0.10Å---
B 495 GLN13.34-Favored (78.85%)
General / -60.1,-37.0
Favored (17.5%) tp40
chi angles: 184.7,76.6,350.3
0.04Å---
B 496 MET24.07-Favored (91.74%)
General / -65.7,-41.9
Favored (17.9%) tmm
chi angles: 178.3,267.2,297.6
0.06Å---
B 497 VAL16.8-Favored (65.97%)
Ile or Val / -72.1,-39.9
Favored (34.7%) t
chi angles: 166.1
0.09Å---
B 498 ARG13.7-Favored (65.47%)
General / -64.4,-19.4
Favored (92.7%) mtt180
chi angles: 288.6,178.9,169.3,178.2
0.12Å---
B 499 SER17.7-Favored (58.61%)
General / -72.2,-9.6
Favored (23.3%) p
chi angles: 78.9
0.06Å---
B 500 GLN15.03-Favored (10.09%)
General / -116.3,-19.6
Favored (58.7%) mt0
chi angles: 296.8,179.8,80
0.03Å---
B 501 ARG11.85-Favored (20.18%)
General / -152.2,140.2
Favored (55.2%) ttt90
chi angles: 179.4,167.4,173.4,85.9
0.02Å---
B 502 SER14.85-Favored (35.54%)
General / -54.9,128.9
Favored (72.5%) m
chi angles: 295.8
0.09Å---
B 503 GLY13.6-Favored (76.56%)
Glycine / 70.4,20.1
-----
B 504 MET14.74-Favored (16.96%)
General / -59.3,123.5
Favored (50.9%) mmm
chi angles: 297.4,281.5,278.2
0.01Å---
B 505 VAL11.72-OUTLIER (0.04)%)
Ile or Val / 73.4,109.6
Favored (35.9%) t
chi angles: 184.3
0.12Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 506 GLN12.36-Favored (13%)
General / -92.2,-36.9
Favored (39.3%) mm-40
chi angles: 281.7,285.3,294.8
0.05Å---
B 507 THR11.47-Favored (37.12%)
General / -133.4,160.5
Favored (69%) p
chi angles: 62.6
0.05Å---
B 508 GLU39.02-Favored (74.5%)
General / -62.9,-33.0
Favored (2.9%) tt0
chi angles: 191.6,212.3,338.1
0.06Å---
B 509 ALA12.76-Favored (97.73%)
General / -62.1,-41.0
-0.06Å---
B 510 GLN11.54-Favored (80.07%)
General / -68.8,-39.1
Favored (89.4%) mt0
chi angles: 291.6,165.8,345.6
0.05Å---
B 511 TYR13.7-Favored (83.77%)
General / -58.9,-47.8
Favored (40.3%) t80
chi angles: 192.2,76.4
0.02Å---
B 512 ARG30.730.57Å
NH1 with B 245 GLN OE1
Favored (96.68%)
General / -62.5,-40.4
Favored (25.9%) mtt-85
chi angles: 288.6,182.8,189.9,239.7
0.06Å---
B 513 PHE10.19-Favored (89.98%)
General / -63.1,-38.1
Favored (87%) t80
chi angles: 180.5,76.3
0.06Å---
B 514 ILE10.41-Favored (81.21%)
Ile or Val / -58.6,-49.8
Favored (69.9%) mt
chi angles: 290.7,161.8
0.11Å---
B 515 TYR13.61-Favored (94.18%)
General / -60.4,-45.2
Favored (6%) m-80
chi angles: 267.6,277.3
0.01Å---
B 516 MET34.770.52Å
HG2 with B 432 PRO HG3
Favored (89.7%)
General / -62.5,-38.4
Favored (9.3%) ttp
chi angles: 161.9,163.9,82.4
0.03Å---
B 517 ALA13.19-Favored (74.96%)
General / -66.3,-47.0
-0.05Å---
B 518 VAL19.61-Favored (95.2%)
Ile or Val / -60.1,-45.9
Favored (70.2%) t
chi angles: 172.1
0.03Å---
B 519 GLN25.710.41Å
HE21 with B 227 GLU HA
Favored (81.05%)
General / -56.6,-46.2
Favored (61.2%) tt0
chi angles: 183.9,182.1,39.4
0.02Å---
B 520 HIS27.03-Favored (86.92%)
General / -67.0,-38.9
Favored (68.3%) t-90
chi angles: 185.6,282.1
0.08Å---
B 521 TYR26.25-Favored (89.73%)
General / -63.7,-45.5
Favored (85.3%) t80
chi angles: 181.9,80.6
0.04Å---
B 522 ILE20.36-Favored (82.18%)
Ile or Val / -66.9,-38.8
Favored (23.5%) mt
chi angles: 287.9,154.9
0.06Å---
B 523 GLU42.09-Favored (66.58%)
General / -57.1,-32.8
OUTLIER (0%)
chi angles: 250.8,122.6,42.4
0.09Å---
B 524 THR38.12-Favored (24.23%)
General / -105.9,17.1
Favored (67.4%) p
chi angles: 58.7
0.08Å---
B 525 LEU40.410.63Å
HD12 with B 484 VAL HG23
-Favored (11.3%) mt
chi angles: 283.4,184.4
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 601 5OD34.570.41Å
H3 with A 249 GLU HG2
------
A 602 PO465.43-------
A 603 PO458.7-------
A 604 PO464.49-------
B 601 5OD330.57Å
H13 with B 249 GLU OE2
------
B 602 PO444.94-------
B 603 PO469.430.45Å
O3 with B 142 SER N
------
B 604 PO468.47-------
A 701 HOH18.87-------
A 702 HOH25.37-------
A 703 HOH26.38-------
A 704 HOH24.89-------
A 705 HOH24.41-------
A 706 HOH25.75-------
A 707 HOH22.06-------
A 709 HOH30.12-------
A 710 HOH17.01-------
A 711 HOH23.43-------
A 712 HOH27.91-------
A 713 HOH31.78-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 714 HOH40.15-------
A 715 HOH29.47-------
A 716 HOH44.24-------
A 717 HOH28.01-------
A 718 HOH31.08-------
A 719 HOH39.33-------
A 720 HOH19.64-------
A 721 HOH33.46-------
A 722 HOH31.12-------
A 723 HOH34.03-------
A 724 HOH50.760.43Å
O with A 32 ARG NH1
------
A 725 HOH40.48-------
A 726 HOH33.79-------
A 727 HOH24.26-------
A 728 HOH32.89-------
A 729 HOH34.39-------
A 730 HOH41.86-------
A 731 HOH38.12-------
A 732 HOH31.41-------
A 733 HOH38.14-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 734 HOH23.15-------
A 735 HOH33.36-------
A 736 HOH29.59-------
A 737 HOH28.54-------
A 738 HOH35.78-------
A 739 HOH23.78-------
A 740 HOH28.1-------
A 741 HOH47.43-------
A 742 HOH33.7-------
A 743 HOH28.99-------
A 744 HOH33.26-------
A 745 HOH28.3-------
A 746 HOH36.93-------
A 747 HOH29.7-------
A 748 HOH26.35-------
A 749 HOH34.35-------
A 750 HOH33.7-------
A 751 HOH32.79-------
A 752 HOH34.98-------
A 753 HOH35.71-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 754 HOH16.18-------
A 755 HOH33.67-------
A 756 HOH34.82-------
A 757 HOH33.79-------
A 759 HOH24.53-------
A 760 HOH34.14-------
A 761 HOH21.23-------
A 762 HOH16.21-------
A 763 HOH23.35-------
A 764 HOH42.07-------
A 765 HOH32.14-------
A 766 HOH44.07-------
A 767 HOH15.43-------
A 768 HOH19.14-------
A 769 HOH32.52-------
A 770 HOH33.75-------
A 771 HOH39.25-------
A 772 HOH39.2-------
A 774 HOH33.43-------
A 775 HOH38.15-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 776 HOH47.07-------
A 777 HOH19.89-------
A 778 HOH37.29-------
A 779 HOH36.06-------
A 780 HOH29.4-------
A 781 HOH40.34-------
A 782 HOH28.56-------
A 783 HOH23.63-------
A 784 HOH35.35-------
A 785 HOH18.98-------
A 786 HOH49.26-------
A 788 HOH54.12-------
A 789 HOH33.98-------
A 790 HOH25.79-------
A 791 HOH16.1-------
A 793 HOH31.53-------
A 794 HOH20.39-------
A 795 HOH41.03-------
A 796 HOH36.87-------
A 797 HOH23.12-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 798 HOH43.46-------
A 799 HOH21.47-------
A 800 HOH38.64-------
A 801 HOH43.76-------
A 802 HOH51-------
A 803 HOH41.89-------
A 804 HOH32.77-------
A 805 HOH46.06-------
A 806 HOH32.45-------
A 807 HOH25.21-------
A 808 HOH31.29-------
A 809 HOH18.31-------
A 810 HOH35.28-------
A 811 HOH19.52-------
A 812 HOH37.59-------
A 813 HOH40.56-------
A 814 HOH22.08-------
A 817 HOH18.98-------
A 818 HOH42.22-------
A 819 HOH48.2-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 820 HOH23.27-------
A 822 HOH16.78-------
A 823 HOH32.41-------
A 824 HOH25.17-------
A 825 HOH38.9-------
A 826 HOH24.63-------
A 827 HOH32.64-------
A 828 HOH23.66-------
A 829 HOH27.34-------
A 830 HOH30.57-------
A 831 HOH28.63-------
A 832 HOH35.4-------
A 833 HOH42.33-------
A 834 HOH51.74-------
A 835 HOH33.61-------
A 836 HOH39.84-------
A 837 HOH27.22-------
A 838 HOH37.01-------
A 839 HOH22-------
A 840 HOH40.42-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 841 HOH47.89-------
A 842 HOH32.58-------
A 843 HOH21.17-------
A 844 HOH42.46-------
A 845 HOH30.4-------
A 846 HOH43.86-------
A 847 HOH24.11-------
A 848 HOH16.4-------
A 849 HOH22.19-------
A 851 HOH44.49-------
A 852 HOH15.2-------
A 853 HOH19-------
A 854 HOH32.29-------
A 855 HOH23.08-------
A 856 HOH34.94-------
A 857 HOH42.69-------
A 858 HOH28.46-------
A 859 HOH21.59-------
A 860 HOH44.45-------
A 861 HOH47.12-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 862 HOH16.36-------
A 863 HOH34.47-------
A 864 HOH26.91-------
A 865 HOH19.45-------
A 866 HOH39.18-------
A 867 HOH50.19-------
A 868 HOH46.23-------
A 869 HOH19.63-------
A 870 HOH30.75-------
A 871 HOH19.12-------
A 872 HOH32.64-------
A 873 HOH31.37-------
A 874 HOH37.15-------
A 875 HOH36.2-------
A 876 HOH45.57-------
A 877 HOH34.35-------
A 878 HOH16.04-------
A 879 HOH40.6-------
A 880 HOH27.78-------
A 881 HOH41.79-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 882 HOH39.71-------
A 883 HOH20.36-------
A 884 HOH33.99-------
A 885 HOH33.62-------
A 886 HOH32.68-------
A 887 HOH41.48-------
A 888 HOH41-------
A 889 HOH36.41-------
A 890 HOH30.35-------
A 891 HOH58.05-------
A 892 HOH26.57-------
A 893 HOH33.25-------
A 894 HOH40.6-------
A 895 HOH31.03-------
A 896 HOH37.55-------
A 897 HOH19.92-------
A 898 HOH27.98-------
A 899 HOH33.77-------
A 900 HOH30.33-------
A 901 HOH16.93-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 902 HOH28.3-------
A 903 HOH43.09-------
A 904 HOH45.49-------
A 905 HOH45.74-------
A 906 HOH35.72-------
A 907 HOH20.85-------
A 908 HOH38.92-------
A 909 HOH39.66-------
A 910 HOH32.15-------
A 911 HOH27.47-------
A 912 HOH43.390.69Å
O with A 325 LYS HD2
------
A 913 HOH41.07-------
A 914 HOH39.47-------
A 915 HOH27.16-------
A 916 HOH40.98-------
A 917 HOH48.28-------
A 918 HOH37.45-------
A 919 HOH32.63-------
A 920 HOH40.51-------
A 921 HOH27.24-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 922 HOH33.89-------
A 923 HOH32.78-------
A 924 HOH20.3-------
A 925 HOH49.14-------
A 926 HOH26.87-------
A 927 HOH39.49-------
A 928 HOH25.24-------
A 929 HOH40.79-------
A 930 HOH31.2-------
A 931 HOH30.91-------
A 932 HOH15.45-------
A 933 HOH23.84-------
A 934 HOH28.86-------
A 935 HOH38.65-------
A 936 HOH20.77-------
A 937 HOH30.1-------
A 938 HOH37.14-------
A 939 HOH31.31-------
A 940 HOH33.05-------
A 941 HOH41.32-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 942 HOH22.48-------
A 943 HOH44.72-------
A 944 HOH39.93-------
A 945 HOH49.89-------
A 946 HOH34.87-------
A 947 HOH42.47-------
A 948 HOH45.77-------
A 949 HOH39.43-------
A 950 HOH36.84-------
A 951 HOH45.76-------
A 952 HOH46.5-------
A 953 HOH46.3-------
A 954 HOH27.41-------
A 955 HOH54.65-------
A 956 HOH26.76-------
A 957 HOH32.73-------
A 958 HOH29.68-------
A 959 HOH38.6-------
A 960 HOH40.46-------
A 961 HOH38.33-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 962 HOH19.94-------
A 963 HOH27.03-------
A 964 HOH29.61-------
A 965 HOH52.06-------
A 966 HOH38.49-------
A 967 HOH22.03-------
A 968 HOH37.57-------
A 969 HOH44.01-------
A 970 HOH30.76-------
A 971 HOH52.85-------
A 974 HOH35.64-------
A 976 HOH37.6-------
A 977 HOH30.1-------
A 978 HOH33.69-------
A 979 HOH26.28-------
A 980 HOH46.48-------
A 981 HOH26.2-------
A 982 HOH46.85-------
A 983 HOH28.5-------
A 984 HOH35.84-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A 985 HOH47.09-------
A 986 HOH37.71-------
A 987 HOH33.74-------
A 989 HOH41.2-------
A 990 HOH41.05-------
A 991 HOH49.65-------
A 992 HOH53.74-------
A 993 HOH36.83-------
A 994 HOH48.53-------
A 995 HOH37.49-------
A 996 HOH40.86-------
A 997 HOH40.31-------
A 998 HOH44.42-------
A 999 HOH35.97-------
A1000 HOH47.67-------
A1001 HOH46.6-------
A1002 HOH35.09-------
A1004 HOH35.27-------
A1005 HOH48.2-------
A1006 HOH29.15-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A1007 HOH64.2-------
A1008 HOH42.19-------
A1009 HOH58.07-------
A1010 HOH50.08-------
A1011 HOH40.35-------
A1012 HOH43.53-------
A1014 HOH39.04-------
A1016 HOH39.44-------
A1017 HOH32.25-------
A1018 HOH43.28-------
A1020 HOH43.39-------
A1021 HOH56.76-------
A1022 HOH41.44-------
A1024 HOH36.86-------
A1025 HOH33.02-------
A1026 HOH47.15-------
A1028 HOH39.55-------
A1029 HOH36.93-------
A1030 HOH46.78-------
A1031 HOH32.5-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
A1032 HOH23.8-------
A1033 HOH44.43-------
A1034 HOH31.42-------
A1035 HOH35.07-------
A1036 HOH43.35-------
A1037 HOH35.1-------
A1038 HOH26.37-------
A1039 HOH35.19-------
A1040 HOH27.16-------
A1041 HOH50.65-------
A1042 HOH46.48-------
A1043 HOH45.58-------
B 701 HOH21.72-------
B 702 HOH25.74-------
B 703 HOH31.42-------
B 705 HOH46.360.43Å
O with B 441 GLU OE1
------
B 706 HOH19.99-------
B 707 HOH30.76-------
B 708 HOH33.41-------
B 709 HOH41.91-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 710 HOH41.44-------
B 712 HOH21.45-------
B 713 HOH25.02-------
B 714 HOH36.68-------
B 715 HOH30.5-------
B 716 HOH29.42-------
B 717 HOH32.82-------
B 718 HOH40.19-------
B 719 HOH25.41-------
B 720 HOH35.16-------
B 721 HOH21.29-------
B 722 HOH33.17-------
B 723 HOH28.35-------
B 724 HOH28.31-------
B 725 HOH19.15-------
B 726 HOH29.99-------
B 727 HOH28.33-------
B 728 HOH31.83-------
B 729 HOH28.71-------
B 730 HOH30.27-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 731 HOH22.38-------
B 732 HOH37.21-------
B 733 HOH27.33-------
B 734 HOH40.81-------
B 735 HOH38.37-------
B 736 HOH19.14-------
B 737 HOH25.85-------
B 739 HOH25.76-------
B 740 HOH41.47-------
B 741 HOH39.34-------
B 742 HOH29.19-------
B 743 HOH28.54-------
B 744 HOH16.98-------
B 746 HOH16.62-------
B 747 HOH39.81-------
B 748 HOH25.46-------
B 750 HOH40.71-------
B 751 HOH27.3-------
B 752 HOH37.13-------
B 753 HOH20.84-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 754 HOH54.74-------
B 755 HOH24.12-------
B 756 HOH37.63-------
B 757 HOH34.96-------
B 758 HOH32.11-------
B 759 HOH20.87-------
B 760 HOH27.34-------
B 761 HOH39.59-------
B 762 HOH52.46-------
B 763 HOH34.35-------
B 764 HOH15.78-------
B 765 HOH46.22-------
B 766 HOH39.55-------
B 767 HOH40.37-------
B 768 HOH28.69-------
B 769 HOH25.14-------
B 770 HOH34.11-------
B 771 HOH25.54-------
B 772 HOH31.38-------
B 773 HOH37.45-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 774 HOH35.98-------
B 775 HOH36.95-------
B 776 HOH14.62-------
B 777 HOH27.73-------
B 778 HOH40.25-------
B 779 HOH36.72-------
B 780 HOH15.13-------
B 781 HOH35.71-------
B 782 HOH34.71-------
B 783 HOH28.08-------
B 784 HOH36.27-------
B 785 HOH45.21-------
B 786 HOH30.53-------
B 788 HOH39.24-------
B 789 HOH28.21-------
B 790 HOH52.32-------
B 791 HOH28.11-------
B 792 HOH32.24-------
B 793 HOH34.76-------
B 794 HOH29.29-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 795 HOH34-------
B 796 HOH34.31-------
B 797 HOH33.9-------
B 798 HOH20.74-------
B 799 HOH44.52-------
B 801 HOH29.08-------
B 802 HOH41.63-------
B 803 HOH41.73-------
B 804 HOH27.06-------
B 805 HOH32.59-------
B 806 HOH47.72-------
B 807 HOH28.79-------
B 808 HOH35.61-------
B 809 HOH29.27-------
B 810 HOH41.7-------
B 811 HOH28.36-------
B 812 HOH25.37-------
B 813 HOH39-------
B 814 HOH38.33-------
B 815 HOH48.1-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 816 HOH32.97-------
B 817 HOH27.55-------
B 818 HOH16.94-------
B 819 HOH27.15-------
B 820 HOH34.02-------
B 821 HOH35.81-------
B 822 HOH35.31-------
B 823 HOH23.01-------
B 825 HOH21.97-------
B 826 HOH38.77-------
B 827 HOH14.93-------
B 828 HOH35.93-------
B 829 HOH39.47-------
B 830 HOH27.91-------
B 831 HOH18.07-------
B 832 HOH23.46-------
B 833 HOH34.74-------
B 834 HOH31.35-------
B 835 HOH25.83-------
B 836 HOH15.58-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 837 HOH38.26-------
B 838 HOH36.93-------
B 839 HOH22.36-------
B 841 HOH48.65-------
B 842 HOH22.94-------
B 843 HOH40.85-------
B 844 HOH41.4-------
B 845 HOH34.31-------
B 846 HOH41.41-------
B 847 HOH15.07-------
B 848 HOH32.78-------
B 849 HOH35.03-------
B 850 HOH24.88-------
B 851 HOH23.95-------
B 852 HOH47.42-------
B 853 HOH24.36-------
B 854 HOH34.93-------
B 856 HOH46.72-------
B 857 HOH41.72-------
B 858 HOH37.33-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 859 HOH27.22-------
B 860 HOH31.78-------
B 862 HOH20.9-------
B 863 HOH18.16-------
B 864 HOH29.46-------
B 865 HOH45.32-------
B 866 HOH42.81-------
B 867 HOH35.02-------
B 868 HOH27.34-------
B 869 HOH31.87-------
B 870 HOH42.35-------
B 871 HOH34.24-------
B 872 HOH35.38-------
B 873 HOH26.56-------
B 874 HOH30.66-------
B 875 HOH25.48-------
B 876 HOH42.14-------
B 877 HOH43.33-------
B 878 HOH45.36-------
B 880 HOH16.32-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 881 HOH32.74-------
B 882 HOH16.07-------
B 883 HOH33.3-------
B 884 HOH28.04-------
B 885 HOH17.1-------
B 886 HOH29.52-------
B 887 HOH24.94-------
B 889 HOH31.42-------
B 890 HOH29.97-------
B 891 HOH26.9-------
B 892 HOH24.1-------
B 893 HOH22.99-------
B 894 HOH32.67-------
B 895 HOH32.33-------
B 896 HOH25.86-------
B 897 HOH23.9-------
B 898 HOH17.7-------
B 899 HOH29.76-------
B 900 HOH48.32-------
B 901 HOH42.14-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 902 HOH33.78-------
B 903 HOH40.28-------
B 904 HOH42.28-------
B 905 HOH38.29-------
B 906 HOH44.45-------
B 907 HOH35.77-------
B 908 HOH45.79-------
B 909 HOH32.76-------
B 911 HOH32.34-------
B 912 HOH21.84-------
B 913 HOH25.37-------
B 914 HOH57.82-------
B 915 HOH30.77-------
B 916 HOH44.37-------
B 917 HOH47.11-------
B 918 HOH34.69-------
B 919 HOH45.34-------
B 920 HOH28.08-------
B 921 HOH28.28-------
B 922 HOH35-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 923 HOH28.06-------
B 924 HOH45.83-------
B 925 HOH23.99-------
B 926 HOH35.53-------
B 927 HOH30.64-------
B 928 HOH38.71-------
B 929 HOH34.53-------
B 930 HOH28.57-------
B 931 HOH36.55-------
B 932 HOH47.8-------
B 933 HOH17.56-------
B 934 HOH35.94-------
B 935 HOH31.88-------
B 936 HOH31.77-------
B 937 HOH21.22-------
B 938 HOH50.98-------
B 939 HOH34.8-------
B 940 HOH32.39-------
B 942 HOH26.88-------
B 943 HOH33.48-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 944 HOH45.27-------
B 945 HOH47.35-------
B 946 HOH38.64-------
B 947 HOH34.1-------
B 948 HOH51.43-------
B 949 HOH23.78-------
B 950 HOH47.2-------
B 951 HOH41.63-------
B 952 HOH30.16-------
B 954 HOH33.11-------
B 955 HOH36.82-------
B 956 HOH44.36-------
B 957 HOH39.16-------
B 958 HOH36.73-------
B 959 HOH34.61-------
B 960 HOH47.79-------
B 961 HOH37.29-------
B 962 HOH49.07-------
B 963 HOH39.82-------
B 964 HOH58.68-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 965 HOH45.15-------
B 966 HOH34.21-------
B 968 HOH29.04-------
B 969 HOH43.57-------
B 970 HOH44.32-------
B 971 HOH33.48-------
B 972 HOH41.37-------
B 973 HOH53.36-------
B 974 HOH26.99-------
B 975 HOH43.59-------
B 976 HOH41.51-------
B 977 HOH32.63-------
B 978 HOH48.88-------
B 979 HOH40.38-------
B 981 HOH34.99-------
B 982 HOH38.9-------
B 983 HOH46.32-------
B 984 HOH55.18-------
B 985 HOH51.78-------
B 986 HOH50.01-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B 987 HOH36.68-------
B 988 HOH54.03-------
B 989 HOH56.03-------
B 990 HOH37.56-------
B 991 HOH39.82-------
B 992 HOH43.14-------
B 993 HOH51.13-------
B 994 HOH41.89-------
B 995 HOH48.33-------
B 997 HOH46.62-------
B 999 HOH41.71-------
B1000 HOH34.32-------
B1001 HOH41.12-------
B1002 HOH34.77-------
B1003 HOH52.68-------
B1004 HOH44.63-------
B1005 HOH33.47-------
B1006 HOH43.93-------
B1007 HOH50.06-------
B1008 HOH41.32-------
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 27.16Clashscore: 3.92Outliers: 4 of 934Poor rotamers: 11 of 855Outliers: 2 of 892Outliers: 2 of 966Outliers: 11 of 966Non-Trans: 0 of 947
B1009 HOH45.88-------
B1010 HOH44.01-------
B1011 HOH35.96-------
B1012 HOH40.11-------
B1013 HOH33.03-------
B1015 HOH43.25-------
B1016 HOH26.72-------
B1017 HOH50.57-------
B1018 HOH43.13-------
B1019 HOH42.26-------
B1020 HOH49.94-------
B1021 HOH44.27-------
B1022 HOH47.43-------
B1023 HOH35.43-------
B1024 HOH33.81-------
B1025 HOH31-------
B1026 HOH41.17-------
B1027 HOH47.66-------